Clarivate Releases EndNote 2025 with AI-Powered Research Tools
- Enhancing research efficiency and accuracy with newly integrated features LONDON , April 23, 2025 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT), a leading global provider of transformative intelligence, today released EndNote 2025, a comprehensive reference management solution that streamlines the research and writing process. Its new features include AI support, enhanced referencing tools, and journal matching capabilities, designed to save researchers time and improve accuracy.
- 04/23/2025
|
Clarivate PLC (CLVT) Expected to Beat Earnings Estimates: Should You Buy?
- Clarivate (CLVT) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
- 04/22/2025
|
Clarivate to Report First Quarter 2025 Results on April 29, 2025
- LONDON , April 2, 2025 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT), a leading global provider of transformative intelligence, announced today it will report its financial results for the first quarter 2025 before the market opens on Tuesday, April 29, 2025. The press release and earnings supplement, with accompanying financial information, will be available on the Clarivate investor website at https://ir.clarivate.com.
- 04/02/2025
|
Clarivate Partners with Iprova to Streamline the Invention Creation and Submission Process
- The partnership will see Iprova's suite of solutions integrated with IP management software IPfolio LONDON , March 18, 2025 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT), a leading global provider of transformative intelligence, today announced a strategic partnership with Iprova, the world's first data-driven invention company and developer of state-of-the-art Artificial Intelligence-based technologies which augment and enhance the human ability to invent. This partnership will combine Iprova's product suite for collaboratively capturing, creating and refining inventive concepts with IPfolio, the industry-leading IP management software, enabling a smooth transition of inventions into the patent workflow.
- 03/18/2025
|
TE Connectivity ranks among Clarivate Top 100 Global Innovators 2025
- List highlights organizations at the forefront of technology research and innovation GALWAY, Ireland , March 12, 2025 /PRNewswire/ -- TE Connectivity, a world leader in connectors and sensors, has been named among the Clarivate Top 100 Global Innovators, an annual list of organizations that prioritize innovation as a business strategy. Innovation is a core value at TE, which has been named a Top 100 Global Innovator 12 times since Clarivate created the recognition in 2012.
- 03/12/2025
|
Philips highest ranked medical technology company among Clarivate Top 100 Global Innovators
- March 12, 2025 Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced it has been recognized by Clarivate as the top-ranked medical technology company in the Top 100 Global Innovators 2025, reinforcing its global reputation as a leading healthcare innovator. A consistent high-performer, Philips has been included in this major assessment of global innovators for 12 consecutive years. Roy Jakobs, CEO of Royal Philips said: "At Philips, we've been innovating for over 130 years to improve people's lives. Innovation is our fundamental strength, the reason why customers choose us as their strategic partner and a key value driver for our company. Our portfolio of patient- and people-centric innovations in hardware, software, AI and services drives healthcare productivity and empowers people to look after their health and well-being – delivering better care for more people." In 2024, Philips invested approximately EUR 1.7 billion – or an industry leading >9% of sales – in research and development to help drive better care for more people. Philips is increasingly focusing its innovation efforts on the potential of data and AI, both in hospital settings and at home. As a leader in AI-related patent applications in healthcare, Philips dedicates around half of its R&D workforce to these fields. Examples of Philips' AI-powered innovations that increase caregiver productivity and deliver better care for more people include:
- 03/12/2025
|
Clarivate Reveals Top 100 Global Innovators 2025
- The Top 100 organizations generate $4.6 trillion USD in annual revenues, representing 4.4% of the global economy LONDON , March 12, 2025 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT), a leading global provider of transformative intelligence, today revealed its 2025 ranked list of Top 100 Global Innovators – the organizations at the forefront of technology research and innovation worldwide. The Top 100 organizations prioritize innovation as a central part of their business strategy.
- 03/12/2025
|
Clarivate Report Explores Opportunities for Innovation and Market Expansion in Latin America
- New insights from Clarivate examine strategic partnerships, API production, and innovation in the region LONDON , Feb. 27, 2025 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT) a leading global provider of transformative intelligence, has released a new white paper, How is Latin America Growing? , shedding light on the pharmaceutical industry's evolution in the region.
- 02/27/2025
|
Clarivate Plc (CLVT) Q4 2024 Earnings Call Transcript
- Clarivate Plc (NYSE:CLVT ) Q4 2024 Earnings Conference Call February 19, 2025 9:00 AM ET Company Participants Mark Donohue - VP of IR Matti Shem Tov - CEO Jonathan Collins - CFO Conference Call Participants Manav Patnaik - Barclays Andrew Nicholas - William Blair George Tong - Goldman Sachs Owen Lau - Oppenheimer Shlomo Rosenbaum - Stifel Surinder Thind - Jefferies Peter Christiansen - Citi Ashish Sabadra - RBC Capital Markets Operator Thank you for standing by. My name is Kate, and I will be your conference operator today.
- 02/19/2025
|
Compared to Estimates, Clarivate (CLVT) Q4 Earnings: A Look at Key Metrics
- Although the revenue and EPS for Clarivate (CLVT) give a sense of how its business performed in the quarter ended December 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
- 02/19/2025
|
Clarivate PLC (CLVT) Q4 Earnings and Revenues Top Estimates
- Clarivate PLC (CLVT) came out with quarterly earnings of $0.21 per share, beating the Zacks Consensus Estimate of $0.20 per share. This compares to earnings of $0.23 per share a year ago.
- 02/19/2025
|
Clarivate Reports Fourth Quarter and Full Year 2024 Results
- — Accelerates transition from transactional to subscription and re-occurring revenue — — Launches new product innovation for Academia & Government and Life Sciences & Healthcare — — Repurchased $200 million ordinary shares and pre-paid $198 million of debt in 2024 as part of balanced capital allocation strategy — — Initiates review of strategic alternatives including potential divestitures — — Provides 2025 Outlook — LONDON , Feb. 19, 2025 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT) (the "Company" or "Clarivate"), a leading global provider of transformative intelligence, today reported results for the fourth quarter and full year ended December 31, 2024. Total revenue for the fourth quarter of 2024 was $663.0 million, compared to total revenue of $683.7 million in the fourth quarter of 2023.
- 02/19/2025
|
Clarivate Unveils Transformative Subscription-Based Access Strategy for Academia
- New approach enables broad, simple and affordable access to trusted scholarly content for learning and research LONDON , Feb. 18, 2025 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT), a leading global provider of transformative intelligence, today announced a new subscription-based content access strategy. The new approach breaks down barriers through broad and affordable access to highly curated, trusted academic resources, including Ebooks and primary digital collections, enabling every library to support research, teaching and learning goals.
- 02/18/2025
|
Exploring Analyst Estimates for Clarivate (CLVT) Q4 Earnings, Beyond Revenue and EPS
- Beyond analysts' top -and-bottom-line estimates for Clarivate (CLVT), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended December 2024.
- 02/17/2025
|
Clarivate Recognized for Excellence in Trademark Business in the WTR 1000 2025
- Highly recommended in trademark management, searching and watching, renewals and recordals LONDON , Feb. 10, 2025 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT), a leading global provider of transformative intelligence, has been recognized by the World Trademark Review for three categories in the WTR 1000 2025 . This guide identifies the top trademark professionals and firms in key jurisdictions around the globe.
- 02/10/2025
|
Clarivate Selected by National and University Library in Zagreb, Croatia to Create a Unified National Library Platform
- Software-as-a-Service, cloud-based library services and discovery platform to be implemented in nine universities and 82 academic and research libraries across Croatia LONDON , Feb. 5, 2025 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT), a leading global provider of transformative intelligence, today announced that the National and University Library in Zagreb has selected Clarivate to provide its unified library services and discovery platform. The National and University Library in Zagreb (NSK) is Croatia's leading cultural and research institution, serving as both the National Library of Croatia and the University of Zagreb's main library.
- 02/05/2025
|
Clarivate Reveals Medtech Breakthroughs Driving Growth in Pulsed Field Ablation Market
- New e-book explores transformative medtech advancements in pulsed field ablation for atrial fibrillation treatment LONDON , Feb. 4, 2025 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT) a leading global provider of transformative intelligence and BioWorld by Clarivate, today published a new e-book, Pulsed field ablation: stunning growth shocks the atrial fibrillation market . The Clarivate e-book highlights new medtech breakthroughs in the pulsed field ablation (PFA) market, forecasting its future growth and showcasing the technology's potential to transform the treatment paradigm for atrial fibrillation.
- 02/04/2025
|
Clarivate identifies top 50 universities powering global innovation
- Report from the Institute for Scientific Information shows how academic research drives global innovation and benefits society LONDON , Jan. 30, 2025 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT), a leading global provider of transformative intelligence, today released The top 50 universities powering global innovation report which analyzes the critical role of research in shaping global industrial innovation and societal impact, using data and expert insights derived from academic research and patent citations. Drawing on a host of Clarivate data - from the Web of Science to Derwent World Patents Index, and Derwent Patents Citation Index – the report highlights how knowledge flows between academia and industry across countries and regions, underscoring the global nature of innovation.
- 01/30/2025
|
The British Library Selects Clarivate to Provide Library Services and Discovery Platforms
- Achieving more unified and secure workflows with cloud-based Alma, Primo and Rapido library software solutions from Clarivate LONDON , Jan. 28, 2025 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT), a leading global provider of transformative intelligence, today announces that the British Library has selected Clarivate to provide its library services and discovery platforms to create a more cohesive, streamlined and secure experience. The British Library will implement Alma, Primo VE and Rapido.
- 01/28/2025
|
Clarivate to Report Fourth Quarter and Full Year 2024 Results on February 19, 2025
- LONDON , Jan. 22, 2025 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT), a leading global provider of transformative intelligence, announced today it will report its financial results for the fourth quarter and full year 2024 before the market opens on Wednesday, February 19, 2025. The press release and earnings supplement, with accompanying financial information, will be available on the Clarivate investor website at https://ir.clarivate.com.
- 01/22/2025
|
Does Clarivate (CLVT) Have the Potential to Rally 29.13% as Wall Street Analysts Expect?
- The average of price targets set by Wall Street analysts indicates a potential upside of 29.1% in Clarivate (CLVT). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
- 01/16/2025
|
BioWorld by Clarivate Releases Comprehensive 2024 Year in Review
- Series Recaps Biopharma, MedTech, and Science Trends and Breakthroughs That Shaped the Year LONDON , Jan. 16, 2025 /PRNewswire/ -- BioWorld™ published by Clarivate Plc (NYSE:CLVT), a leading global provider of transformative intelligence, has released its highly anticipated 2024 Year in Review series. This multipart special report offers an in-depth analysis of the therapeutic trends, regulatory actions and economic shifts that defined biopharma, med tech and scientific innovation over the past year while forecasting key developments for 2025.
- 01/16/2025
|
Post-marketing Pharmacovigilance and Medical Information Market Research 2024: Rising Adverse Drug Reactions (ADRs) and Expanding Use of Biologics and Specialty Drugs Fueling Growth - Forecast to 2034
- Dublin, Jan. 14, 2025 (GLOBE NEWSWIRE) -- The "Post-marketing Pharmacovigilance and Medical Information Market by Type by Service, by End-User, and By Region" report has been added to ResearchAndMarkets.com's offering. The global post-marketing pharmacovigilance and medical information market size was estimated to be USD 6.22 billion in 2023 and is expected to reach USD 16.99 billion by 2034 with a CAGR of 9.56% during the forecast period 2024-2034.
- 01/14/2025
|
Clarivate Launches DRG Fusion - A New Life Sciences Analytics Product Powered by Real-World Data
- New modular analytics solution empowers commercial teams to optimize strategies and improve patient outcomes LONDON , Jan. 14, 2025 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT), a leading global provider of transformative intelligence, today announced the launch of DRG Fusion, an innovative platform to support commercial analytics in life sciences. Powered by integrated real-world data and built by clinical and data science experts, Fusion provides biopharma and medtech organizations with the tools to understand and act in varied disease and competitive landscapes — eliminating the complexities of raw data management.
- 01/14/2025
|
Clarivate Identifies Eleven Potential Blockbuster and Transformative Drugs in Annual Drugs to Watch Report
- Anticipated advancements in obesity, oncology, gene therapy and other areas poised to revolutionize patient care LONDON , Jan. 8, 2025 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT) a leading global provider of transformative intelligence, today announced the release of the twelfth annual Drugs to Watch™ report, a trusted guide to the therapies poised to redefine the future of healthcare. This year, the highly anticipated resource highlights 11 drugs projected to achieve blockbuster status or revolutionize treatment paradigms within five years.
- 01/08/2025
|
Clarivate Announces New $500 Million Share Repurchase Authorization
- LONDON , Dec. 16, 2024 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT) (the "Company" or "Clarivate"), a leading global provider of transformative intelligence, today announced that its Board of Directors (the "Board") authorized a new share repurchase program of up to $500 million of the Company's outstanding ordinary shares through open-market purchases for a period of two years, from January 1, 2025 through December 31, 2026. The new share repurchase program replaces the current share repurchase program which terminates December 31, 2024, under which the Company repurchased $300 million of ordinary shares, including $200 million during the third and fourth quarters of 2024.
- 12/16/2024
|
Clarivate Launches AI-Powered Patent Search Solution in Derwent
- Faster and more relevant results to empower critical IP decision-making LONDON , Dec. 12, 2024 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT), a leading global provider of transformative intelligence, today announced the launch of AI Search in Derwent™. Combining artificial intelligence (AI) with the premier source of global patent data, Derwent World Patents Index (DWPI)™, this solution will enable intellectual property (IP) professionals to make reliable innovation decisions by finding more relevant patents in less time.
- 12/12/2024
|
Bargains Galore? 3 Stocks With Insider Buying in the Millions
- It's widely believed that insiders know how well a company is operating. Therefore, when insiders are actively buying their stock, it is assumed they must know something that's motivating them to buy shares.
- 12/10/2024
|
Clarivate and the Chinese Academy of Sciences Release Annual Collaborative Report to Identify 125 Research Fronts
- Revealing highly active specialties in sciences and social sciences LONDON , Nov. 27, 2024 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT), a leading global provider of transformative intelligence, and the Chinese Academy of Sciences (CAS) today released 2024 Research Fronts™, identifying the most dynamic and rapidly growing specialties in sciences and social sciences. This marks the eleventh annual collaboration between the two organizations, with the report launched at a ceremony held in Beijing today.
- 11/27/2024
|
Daikin Selects IPfolio from Clarivate
- Enhancing operational efficiency for leading air conditioner manufacturer LONDON , Nov. 27, 2024 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT), a leading global provider of transformative intelligence, announced today that Daikin Industries, Ltd. (Daikin) has selected IPfolio™ from Clarivate.
- 11/27/2024
|
BioWorld by Clarivate Highlights Gaps in Women's Health Research and Investment in New Special Series
- New seven-part series explores disparities in care, funding and innovation impacting half the world's population LONDON , Nov. 21, 2024 /PRNewswire/ -- BioWorld ™ published by Clarivate Plc (NYSE:CLVT), a leading global provider of transformative intelligence, has launched its new special series, 'Healing the Health Divide. ' This seven-part series sheds light on the persistent disparities in women's health research, funding, and treatment.
- 11/21/2024
|
Clarivate Reveals Highly Cited Researchers 2024 List
- Prioritizing research integrity with enhanced filters to address publication and citation manipulation LONDON , Nov. 19, 2024 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT), a leading global provider of transformative intelligence, today revealed its 2024 list of Highly Cited Researchers™ – influential researchers at universities, research institutes and commercial organizations around the world who have demonstrated significant and broad influence in their field(s) of research. Analysts at the Institute for Scientific Information (ISI)™ have recognized 6,636 Highly Cited Researchers in 2024 from more than 1,200 institutions in 59 nations and regions.
- 11/19/2024
|
New Report from Clarivate and Healthcare Executive Explores Mainland China's Biopharma Revolution and Increasing Global Influence
- New report analyses Mainland China's transformation into a global biopharma powerhouse, with key insights for international stakeholders LONDON , Nov. 18, 2024 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT) a leading global provider of transformative intelligence, in partnership with Healthcare Executive, published by the China Pharmaceutical Enterprises Association, today announced the release of a new report, A Decade of Innovation, A Decade to Come . Over the past decade, Mainland China's biopharmaceutical sector has rapidly advanced to become a global leader in innovation, ranking among the top three for initial drug launches.
- 11/18/2024
|
Clarivate Healthcare Business Insights Unveils 2023 Revenue Cycle Award Winners
- Recognizing Roper St. Francis Healthcare, Bon Secours Mercy Health, and Bronson Methodist Hospital for excellence in Physician and Hospital Groups LONDON , Nov. 13, 2024 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT) a leading global provider of transformative intelligence, announced the 2023 winners of the Clarivate Healthcare Business Insights™ annual Revenue Cycle Awards. Now in its 12th year, the Revenue Cycle Awards recognize U.S.-based healthcare organizations for exceptional performance on revenue cycle KPIs, based on data from their most recent and preceding full fiscal years.
- 11/13/2024
|
Clarivate Publishes 2023 Sustainability Report
- LONDON , Nov. 12, 2024 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT), a leading global provider of transformative intelligence, has today published its fourth annual sustainability report, showcasing its commitment to sustainability and the United Nations Sustainable Development Goals (SDGs). In 2023, Clarivate was shortlisted for the SDG Pioneer Award at the Thomson Reuters Responsible Business Awards.
- 11/12/2024
|
Clarivate: Downgrade To Hold As Growth May Take A Long Time To Recover
- I downgrade Clarivate PLC from buy to hold due to lack of confidence in near-term organic growth recovery and potential further stock price decline. CLVT's 3Q24 earnings report showed a 3.9% revenue decline and worsening organic growth, marking the worst performance in its history. The new CEO's Value Creation Plan is promising but will take a long time to show results, adding to the uncertainty.
- 11/08/2024
|
Clarivate Launches New Sustainability Research Solution
- ProQuest One Sustainability offers a transdisciplinary research experience and features AI-powered ProQuest Research Assistant LONDON , Nov. 7, 2024 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT), a leading global provider of transformative intelligence, today announced the launch of ProQuestTM One Sustainability. The new solution is an expansive, curated, multi-format content collection designed to meet the growing demand for sustainability curricula across research, teaching and learning.
- 11/07/2024
|
Clarivate Plc (CLVT) Q3 2024 Earnings Call Transcript
- Clarivate Plc (NYSE:CLVT ) Q3 2024 Earnings Conference Call November 6, 2024 9:00 AM ET Company Participants Mark Donohue - Vice President of Investor Relations Matti Shem Tov - Chief Executive Officer Jonathan Collins - Chief Financial Officer Conference Call Participants Owen Lau - Oppenheimer David Paige - RBC Toni Kaplan - Morgan Stanley Andrew Nicholas - William Blair Manav Patnaik - Barclays Shlomo Rosenbaum - Stifel Peter Christiansen - Citi George Tong - Goldman Sachs Colton Feldmann - Jefferies Operator Hello, and thank you for standing by. My name is Regina and I will be your conference operator today.
- 11/06/2024
|
Clarivate (CLVT) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates
- The headline numbers for Clarivate (CLVT) give insight into how the company performed in the quarter ended September 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
- 11/06/2024
|
Clarivate PLC (CLVT) Matches Q3 Earnings Estimates
- Clarivate PLC (CLVT) came out with quarterly earnings of $0.19 per share, in line with the Zacks Consensus Estimate. This compares to earnings of $0.21 per share a year ago.
- 11/06/2024
|
Clarivate Reports Third Quarter 2024 Results
- LONDON , Nov. 6, 2024 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT) (the "Company" or "Clarivate"), a leading global provider of transformative intelligence, today reported results for the third quarter ended September 30, 2024. Third Quarter 2024 Financial Highlights Revenues of $622.2 million decreased 3.9% Organic revenues decreased 2.6%, as an increase in subscription revenues of 0.6% was offset by a decrease in re-occurring revenues of 1.1% and transactional and other revenues of 13.6% Net loss of $65.6 million; Net loss per diluted share of $0.09 Adjusted net income(1) of $134.1 million decreased 12.1%; Adjusted diluted EPS(1) of $0.19 decreased 9.5% or $0.02 Adjusted EBITDA(1) of $264.4 million decreased 6.0%; Adjusted EBITDA margin(1) of 42.5% decreased 100 basis points primarily due to lower revenues Net cash provided by operating activities of $202.9 million increased $39.5 million; Free cash flow(1) of $126.3 million increased $24.6 million primarily due to the timing of working capital Nine Months Ended September 30, 2024 Financial Highlights Revenues of $1,893.7 million decreased 2.6% Organic revenues decreased 1.5% as an increase in subscription revenues of 1.2% was offset by a decline in re-occurring revenues of 2.3% and transactional and other revenues of 9.3% Net loss of $444.9 million; Net loss per diluted share of $0.69 Adjusted net income(1) of $379.8 million decreased 12.8%; Adjusted diluted EPS(1) of $0.52 decreased 11.9% or $0.07 Adjusted EBITDA(1) of $775.1 million decreased 5.4%; Adjusted EBITDA margin(1) of 40.9% decreased 120 basis points primarily due to lower revenues Net cash provided by operating activities decreased $48.0 million to $505.3 million; Free cash flow(1) decreased $76.3 million to $298.4 million primarily due to lower operating income and increased capital expenditures "Clarivate's third quarter results are unsatisfactory and reflect an overdependency on fluctuating transactional revenue and areas of the business with low margin characteristics," said Matti Shem Tov, Chief Executive Officer.
- 11/06/2024
|
What Analyst Projections for Key Metrics Reveal About Clarivate (CLVT) Q3 Earnings
- Get a deeper insight into the potential performance of Clarivate (CLVT) for the quarter ended September 2024 by going beyond Wall Street's top -and-bottom-line estimates and examining the estimates for some of its key metrics.
- 11/05/2024
|
Clarivate PLC (CLVT) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 Release
- Clarivate (CLVT) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
- 10/30/2024
|
Thompson Street Portfolio Company Silverchair Announces Agreement to Acquire Scholarone
- ST. LOUIS--(BUSINESS WIRE)--Silverchair, a portfolio company of Thompson Street Capital Partners (TSCP), announced today that is has entered into a definitive agreement with Clarivate Plc (NYSE:CLVT) to acquire ScholarOne, a leading provider of software and services to scholarly publishers and societies. Terms of the transaction were not disclosed. Founded in 1993 and based in Charlottesville, VA, Silverchair provides a suite of software and services to leading global publishers of scientific,.
- 10/29/2024
|
Clarivate to Report Third Quarter 2024 Results on November 6, 2024
- LONDON , Oct. 16, 2024 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT), a leading global provider of transformative intelligence, announced today it will report its financial results for the third quarter 2024 before the market opens on Wednesday, November 6, 2024. The press release and earnings supplement, with accompanying financial information, will be available on the Clarivate investor website at https://ir.clarivate.com.
- 10/16/2024
|
Clarivate Repeats Success in Nobel Prize Predictions with Eight New Winners Identified by Citation Laureates Program
- 83 Citation Laureates named by the Institute for Scientific Information have received a Nobel Prize since 2002 LONDON , Oct. 15, 2024 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT), a leading global provider of transformative intelligence, today announced the success of its annual Citation Laureates™ program, following the accurate forecast of eight Nobel Prize 2024 recipients. Powered by trusted, high-quality data from the Web of Science Core Collection™ citation index, the Citation Laureates program combines rigorous citation analysis with expert qualitative insights to pinpoint researchers with exceptional citation records who have the potential to receive Nobel honors.
- 10/15/2024
|
Clarivate in partnership with Abiquifi Announces Annual Summit LATAM Agenda
- Top industry leaders to explore AI, data, strategic partnerships, and innovation opportunities in Latin America at premier Life Sciences event LONDON , Oct. 4, 2024 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT) a leading global provider of transformative intelligence, today announced the full agenda for the 2nd annual Summit LATAM, which will be held in Milan on October 7, 2024, ahead of the CPHI Milan conference. In partnership with the Brazilian Association of the Pharmaceutical Ingredients Industry (Abiquifi), this year's event reinforces the industry's commitment to patient welfare by showcasing how collective efforts and innovative strategies are reshaping the pharmaceutical ecosystem, with a focus on navigating market challenges and uncovering innovation opportunities.
- 10/04/2024
|
Clarivate Unveils Comprehensive Framework to Evaluate the Societal Impact of Research
- LONDON , Sept. 25, 2024 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT), a leading global provider of transformative intelligence, today announced the development of a comprehensive framework for evaluating the societal impact of research.
- 09/25/2024
|
New Clarivate Report Reveals Challenges and Trends Shaping IP Operations
- Sharing benchmarks and strategies to elevate IP practices LONDON , Sept. 24, 2024 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT), a leading global provider of transformative intelligence, today released a new survey-based report that reveals insights and best practices for optimizing intellectual property (IP) operations.
- 09/24/2024
|
Clarivate and Relatable Healthcare Forge Strategic Partnership to Transform Medtech Sales Contracting Process
- Clarivate Medtech Intelligence and Relatable software enhance product data management and competitive conversion efficiency for medtech sales, contracting and pricing teams LONDON , Sept. 23, 2024 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT), a leading global provider of transformative intelligence, today announced a strategic partnership with Relatable Healthcare, a technology company delivering Product Relationship Management (PRM) software to leading medtech companies to drive revenue and workflow efficiency.
- 09/23/2024
|
Clarivate Reveals Citation Laureates 2024
- Annual recognition highlights researchers with extraordinary citation records and societal impact, poised for Nobel recognition LONDON , Sept. 19, 2024 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT), a leading global provider of transformative intelligence, today unveiled the Citation Laureates™ 2024 list – used to forecast future Nobel Prize recipients.
- 09/19/2024
|
Clarivate Announces 15th Annual Pharmavision India Conference Agenda
- Industry leaders to discuss AI in healthcare, cell and gene therapy, market access and more at premier life sciences event LONDON , Sept. 18, 2024 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT) a leading global provider of transformative intelligence, today announced the full agenda for the 15th annual Clarivate Pharmavision India conference.
- 09/18/2024
|
Clarivate Launches Generative AI-Powered Primo Research Assistant
- Transforming library discovery with Academic AI that provides users a new and easy way to find trusted content LONDON , Sept. 18, 2024 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT), a leading global provider of transformative intelligence, today launched Primo™ Research Assistant.
- 09/18/2024
|
Clarivate Report Unveils the Transformative Role of Artificial Intelligence on Shaping the Future of the Library
- LONDON , Sept. 9, 2024 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT), a leading global provider of transformative intelligence, today launched its first Pulse of the LibraryTM report.
- 09/09/2024
|
Clarivate to Present at the Goldman Sachs Communacopia + Technology Conference on September 12
- LONDON , Sept. 5, 2024 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT), a leading global provider of transformative intelligence, announced today that Jonathan Collins, Executive Vice President and Chief Financial Officer, will present at the Goldman Sachs Communacopia + Technology Conference, on Thursday, September 12, 2024 at 8:50 am Pacific Time (11:50 am Eastern Time).
- 09/05/2024
|
Clarivate Launches Generative AI-Powered Web of Science Research Assistant
- Developed in partnership with the research community to implement high-quality AI tools responsibly LONDON , Sept. 4, 2024 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT), a leading global provider of transformative intelligence, today released the Web of Science™ Research Assistant.
- 09/04/2024
|
Clarivate Names Melanie Margolin as Chief Administrative and Legal Officer
- LONDON , Aug. 20, 2024 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT), a leading global provider of transformative intelligence, has appointed Melanie Margolin to the expanded role of Chief Administrative and Legal Officer. She joined the company as Executive Vice President and Chief Legal Officer in September 2023.
- 08/20/2024
|
Clarivate: Attractive Upside Even With Conservative Assumptions
- A buy rating is recommended for Clarivate due to the expected organic growth improvement. Recent earnings showed a revenue decline, but organic growth showed a positive recovery, particularly in the A&G and IP segments. Valuation is cheap at 6.5x forward PE, with potential for multiple expansions as growth accelerates.
- 08/09/2024
|
Clarivate to Present at the Oppenheimer 27th Annual Technology, Internet & Communications Virtual Conference on August 12
- LONDON , Aug. 7, 2024 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT), a leading global provider of transformative intelligence, announced today that Jonathan Collins, Executive Vice President and Chief Financial Officer, will present at the Oppenheimer 27th Annual Technology, Internet & Communications Virtual Conference, on Monday, August 12, 2024 at 2:55 pm Eastern Time. The live webcast can be accessed at https://wsw.com/webcast/oppenheimer37/clvt/2805750 and will be available for replay.
- 08/07/2024
|
Clarivate Plc (CLVT) Q2 2024 Earnings Call Transcript
- Clarivate Plc (NYSE:CLVT ) Q2 2024 Earnings Conference Call August 6, 2024 9:00 AM ET Company Participants Mark Donohue - Vice President of Investor Relations Andrew Snyder - Chairman of the Board Jonathan Gear - Chief Executive Officer, Matti Shem Tov - Jonathan Collins - Chief Financial Officer Conference Call Participants Toni Kaplan - Morgan Stanley Manav Patnaik - Barclays Surinder Thind - Jefferies Shlomo Rosenbaum - Stifel Wahid Amin - Bank of America Owen Lau - Oppenheimer Andrew Nicholas - William Blair Ashish Sabadra - RBC Capital Markets George Tong - Goldman Sachs Operator Good morning. Thank you for attending the Clarivate Q2 2024 Earnings Conference Call.
- 08/06/2024
|
Compared to Estimates, Clarivate (CLVT) Q2 Earnings: A Look at Key Metrics
- While the top- and bottom-line numbers for Clarivate (CLVT) give a sense of how the business performed in the quarter ended June 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
- 08/06/2024
|
Clarivate PLC (CLVT) Surpasses Q2 Earnings Estimates
- Clarivate PLC (CLVT) came out with quarterly earnings of $0.20 per share, beating the Zacks Consensus Estimate of $0.18 per share. This compares to earnings of $0.21 per share a year ago.
- 08/06/2024
|
Clarivate Appoints Former ProQuest CEO Matti Shem Tov as the Company's Next CEO
- Chief Executive Jonathan Gear to Step Down as CEO and Member of the Board LONDON , Aug. 6, 2024 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT), a leading global provider of transformative intelligence, today announced that the Board has appointed Matti Shem Tov, former CEO of ProQuest, as the Company's next CEO, effective August 9, 2024. Mr. Shem Tov will also join the Company's Board of Directors.
- 08/06/2024
|
Clarivate Reports Second Quarter 2024 Results
- — Reaffirms 2024 Outlook — LONDON , Aug. 6, 2024 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT) (the "Company" or "Clarivate"), a leading global provider of transformative intelligence, today reported results for the second quarter ended June 30, 2024. Second Quarter 2024 Financial Highlights Revenues of $650.3 million decreased 2.8% Organic revenues decreased 0.6%, as an increase in subscription revenues of 0.7% was offset by a decrease in re-occurring revenues of 0.7% and transactional and other revenues of 4.1% Net loss of $304.3 million; Net loss per diluted share of $0.46 Adjusted net income(1) of $142.2 million decreased 6.6%; Adjusted diluted EPS(1) of $0.20 decreased 4.8% or $0.01 Adjusted EBITDA(1) of $274.4 million decreased 3.7%; Adjusted EBITDA margin(1) of 42.2% decreased 40 basis points primarily due to lower revenues Net cash provided by operating activities of $126.2 million decreased $36.2 million; Free cash flow(1) of $60.3 million decreased $44.5 million primarily due to the timing of working capital Six Months Ended June 30, 2024 Financial Highlights Revenues of $1,271.5 million decreased 2.0% Organic revenues decreased 1.1% as an increase in subscription revenues of 1.5% was offset by a decline in re-occurring revenues of 2.9% and transactional and other revenues of 7.3% Net loss of $379.3 million; Net loss per diluted share of $0.61 Adjusted net income(1) of $245.7 million decreased 13.2%; Adjusted diluted EPS(1) of $0.34 decreased 12.8% or $0.05 Adjusted EBITDA(1) of $510.7 million decreased 5.0%; Adjusted EBITDA margin(1) of 40.2% decreased 120 basis points primarily due to lower revenues Net cash provided by operating activities decreased $87.5 million to $302.4 million; Free cash flow(1) decreased $100.9 million to $172.1 million primarily due to lower operating income and increased capital expenditures "We continue to invest in innovation and make progress on our strategy of returning to growth.
- 08/06/2024
|
Clarivate Introduces New OFF-X ™ Platform for Preclinical and Clinical Safety Intelligence
- Empowering biopharma with enhanced safety insights to anticipate risks and unlock new competitive advantages LONDON , July 30, 2024 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT) a leading global provider of transformative intelligence, today announced the launch of the new OFF-X™ platform. The enhanced solution offers a seamless user experience and unique translational insights.
- 07/30/2024
|
Clarivate Director Richard Roedel to Retire from Board of Directors
- Valeria Alberola to Succeed as Audit Committee Chair LONDON , July 24, 2024 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT), a leading global provider of transformative intelligence, announced today that Richard Roedel will retire from the Board of Directors (the "Board") for health reasons, effective December 31, 2024. The Board expects Valeria Alberola, a member of the Board since May 2021, and a member of its Audit and Finance Committees, to succeed Mr.
- 07/24/2024
|
Clarivate (CLVT) to Develop Unified Library Solution for Ohio
- Clarivate (CLVT) partners with OhioLINK and SearchOhio to integrate their INN-Reach platforms to develop a unified library solution for the state of Ohio.
- 07/22/2024
|
Clarivate Acquires Rowan TELS to Enhance Support for Patent Practitioners
- Delivering integrated, AI-enabled solutions specifically designed for patent preparation and prosecution LONDON , July 22, 2024 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT), a leading global provider of transformative intelligence, today announced it has acquired Rowan TELS Corp. through a subsidiary. Rowan TELS Corp. is the provider of Rowan Patents – an integrated patent drafting and prosecution solution specially designed for patent practitioners to establish and protect patents more effectively.
- 07/22/2024
|
BioWorld by Clarivate Celebrates Nine Wins at 2024 APEX Awards
- Recognized for excellence in writing, news, mental health, financial/investment and economics categories LONDON , July 18, 2024 /PRNewswire/ -- BioWorld™ published by Clarivate Plc (NYSE:CLVT), a leading global provider of transformative intelligence, has been honored with nine 2024 APEX Awards for Publication Excellence. This achievement underscores the BioWorld mission to deliver superior journalistic excellence, data-driven analysis and cutting-edge digital publishing.
- 07/18/2024
|
Clarivate to Partner with OhioLINK and SearchOhio to Create a New Unified Library Experience Across the State of Ohio
- Bringing together Ohio's public and academic libraries' platforms to enhance and streamline customer-centric library resource sharing LONDON , July 18, 2024 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT), a leading global provider of transformative intelligence, today announced a partnership with OhioLINK, Ohio's academic library consortium, and SearchOhio, a consortium of Ohio public libraries, to develop a new library resource sharing consortial experience. Through this partnership Clarivate will unify OhioLINK and SearchOhio's resource sharing platforms to enhance library user experiences and services, improve operational efficiencies and build upon existing consortia collaboration.
- 07/18/2024
|
Clarivate to Report Second Quarter 2024 Results on August 6, 2024
- LONDON , July 16, 2024 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT), a leading global provider of transformative intelligence, announced today it will report its financial results for the second quarter 2024 before the market opens on Tuesday, August 6, 2024. The press release and earnings supplement, with accompanying financial information, will be available on the Clarivate investor website at https://ir.clarivate.com.
- 07/16/2024
|
Clarivate Annual G20 Scorecard Examines Global Research and Innovation Trends Across G20 Members
- Dynamic, interactive data visualizations reveal comprehensive view of the global research and innovation landscape LONDON , July 16, 2024 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT), a leading global provider of transformative intelligence, today released its annual G20 scorecard, compiled by expert analysts and data scientists at the Institute for Scientific Information (ISI)™. The annual G20 research and innovation scorecard examines the research and innovation capabilities of each G20 member through dynamic, interactive data visualizations.
- 07/16/2024
|
Clarivate Reveals First Year of Unitary Patent Court Litigation Activity
- Consistency in infringement cases with an average of ten filings per month LONDON , July 10, 2024 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT), a leading global provider of transformative intelligence, today launched the report One year later in the UPC: First insights from Darts-ip™ , which analyzes litigation data from the Unitary Patent Court's (UPC) inaugural year. The analysis sheds light on the future direction of the UPC and its continued role alongside the European national courts and other major global patent jurisdictions.
- 07/10/2024
|
Clarivate: The Cheapest AI Stock Worth Buying?
- Clarivate NYSE: CLVT may not be the cheapest AI stock worth buying, but it is inexpensive and set up to rebound strongly over the next few quarters. Trading at a mere 7.5x its earnings outlook for 2025, it is a super-deep value compared to leading AI plays, and the estimates for earnings growth underestimate the company's potential.
- 07/03/2024
|
Clarivate Identifies Six Breakthrough MedTech Trends in 2024 Set to Unlock New Industry Opportunities
- New report highlights challenges and opportunities in resilient MedTech industry LONDON , July 2, 2024 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT), a leading global provider of transformative intelligence, today announced the release of the MedTech Trends to Watch 2024 report, the second installment in a two-part series offering a predictive analysis of emerging trends shaping the MedTech industry. Highlighting both challenges—such as economic uncertainty, regulatory shifts and fragile supply chains—and opportunities such as the rise of ambulatory surgical centers and AI in MedTech, the report provides a comprehensive outlook on industry trajectory.
- 07/02/2024
|
Clarivate Report Demonstrates Societal Impact of Digital Health Research and Innovation Growth
- LONDON , June 27, 2024 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT), a leading global provider of transformative intelligence, today released a Global Research Report from the Institute for Scientific Information (ISI)™. The report integrates and interprets multiple data sources from across Clarivate™ portfolios to highlight the academic and societal benefits of the rapidly evolving landscape of digital health.
- 06/27/2024
|
Top 5 Stocks to Watch for AI-Driven Gains That Aren't NVIDIA
- Goldman Sachs NYSE: GS released a list of their top 50 stocks based on expected AI-driven earnings leverage. The firm ranked companies across sectors according to forecasted productivity gains linked to AI-powered automation.
- 06/24/2024
|
Clarivate Launches IP Collaboration Hub
- Enabling users to save time and reduce risks in the IP filing and prosecution process LONDON , June 24, 2024 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT), a leading global provider of transformative intelligence, today launched the IP Collaboration Hub™ at the 2024 Clarivate Ignite conference held in San Diego, U.S. The new solution integrates with Clarivate IP management systems (IPMS) to provide a central hub for collaborating with local agents worldwide. The IP Collaboration Hub enables users to save time and reduce risks in the IP filing and prosecution process by providing a portal for instructors and local agents to collaborate and exchange information, while automatically docketing everything in the IPMS.
- 06/24/2024
|
Clarivate Reveals World's Leading and Trusted Journals with the 2024 Journal Citation Reports
- Adds Emerging Sources Citation Index™ for a simplified and unified category view LONDON , June 20, 2024 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT), a leading global provider of transformative intelligence, today released the 2024 update to the Journal Citation Reports™ (JCR™). The reports provide an essential and comprehensive resource of high-quality journals, ranked by field to enable academic institutions, researchers and publishers to gauge the significance of journals in the global research landscape.
- 06/20/2024
|
Clarivate Identifies Seven Innovators in Antibody Drug Conjugates in New Companies to Watch Report
- Emerging standouts set to transform drug discovery and development, revolutionize cancer treatment, and capture big pharma interest highlighted in third annual report LONDON , June 19, 2024 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT), a leading global provider of transformative intelligence, has released its annual Companies to Watch report, highlighting seven innovative companies revolutionizing drug discovery and development. These companies are advancing antibody-drug conjugates (ADCs) to deliver highly targeted cancer treatments with minimal side effects.
- 06/19/2024
|
Clarivate Launches Research Horizon Navigator to Pinpoint Future Breakthrough Areas
- Insights from the new InCites Benchmarking & Analytics module support strategic investment and demonstrate impact LONDON , June 4, 2024 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT), a leading global provider of transformative intelligence, today launched Research Horizon Navigator™, a powerful new AI-native module within InCites Benchmarking & Analytics™ that highlights emerging research topics where future breakthroughs are likely to occur. Academics, funding agencies, government research organizations and research strategists will be able to identify new research trends and determine the most impactful areas for future investments and strategies.
- 06/04/2024
|
Clarivate Expands Real-World Data Offering with Addition of Social Determinant of Health (SDoH) Attributes from HealthWise Data
- Strategic collaboration enhances insight into patient demographics and behaviors, enabling analytical precision in addressing population health outcomes LONDON, May 31, 2024 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT), a leading global provider of transformative intelligence, today announced a strategic partnership with HealthWise Data, a leading healthcare data and analytics firm bridging the gap between clinical outcomes and Social Determinants of Health (SDoH) domains. The collaboration integrates SDoH attributes into the Clarivate Real-World Data repository, offering comprehensive patient insights and enabling life science, healthcare and research professionals to enhance patient outcomes and healthcare equity.
- 05/31/2024
|
Clarivate Announces Conversion Date and Conversion Rate for Series A Mandatory Convertible Preferred Shares
- LONDON , May 30, 2024 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT; CLVT PR A) ("Clarivate"), a leading global provider of transformative intelligence, announced today that its 5.25% Series A Mandatory Convertible Preferred Shares (the "Preferred Shares"), will automatically and mandatorily convert into ordinary shares of Clarivate on June 3, 2024 (the "Conversion Date"). The mandatory conversion rate for each Preferred Share will be 3.8462 ordinary shares of Clarivate.
- 05/30/2024
|
Clarivate Plc: Still A Buy, But Recovery Could Take Longer Than Expected
- Clarivate reported weak 1Q24 results, with revenue falling and organic growth dipping into negative territory. Despite the disappointing results, I still believe Clarivate is an attractive buy, as the weak growth is attributed to macroeconomic factors rather than structural issues. I expect organic growth to recover once the macro environment improves.
- 05/30/2024
|
Clarivate Celebrates 500 Institutions Adopting Rialto Marketplace Solution
- Transforming the way libraries select, acquire and manage their collections of academic books LONDON , May 30, 2024 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT), a leading global provider of transformative intelligence, today announces that 500 institutions around the world have selected the Rialto™ books marketplace solution with Florida Atlantic University as the 500th customer. This milestone, achieved in just a few years, underscores Rialto's rapid adoption and success in transforming the way libraries acquire and manage their academic book collections so they can best serve their communities.
- 05/30/2024
|
Clarivate to Present at Upcoming Investor Conferences in June 2024
- LONDON , May 29, 2024 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT) (the "Company" or "Clarivate"), a leading global provider of transformative intelligence, today announced that the Company will present at the following investor conferences in June 2024: Jonathan Gear, Chief Executive Officer, will present at the William Blair Growth Stock Conference on Tuesday, June 4, 2024, at 2:00 p.m. Central Time (3:00 p.m.
- 05/29/2024
|
Clarivate Identifies Five Breakthrough Medical Technologies Set to Transform Patient Care in 2024
- New report highlights innovations poised to drive significant clinical and market impact LONDON , May 22, 2024 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT), a leading global provider of transformative intelligence, today announced the release of the Medical Technologies to Watch in 2024 report. This first installment of a two-part series offers a comprehensive predictive analysis of high-growth medical technology markets poised to generate over $1 billion in value or achieve double-digit growth within the next five years.
- 05/22/2024
|
New Clarivate Report Indicates Solid Growth in 2024 Global Trademark Filing Activity
- Analyzing six of the key trademark registers from around the world LONDON , May 21, 2024 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT), a leading global provider of transformative intelligence, today released the Trademark Filing and Litigation Trends 2024 Report, analyzing six of the key trademark registers from around the world: the United States (U.S.), the European Union (EU), the United Kingdom (U.K.), Mainland China, Japan, and South Korea. The report reveals that trademark filing activity worldwide saw a return to stability and growth in 2023 after three years of market volatility, indicating solid growth in 2024.
- 05/21/2024
|
Charles Schwab Investment Management Inc. Boosts Holdings in Clarivate Plc (NYSE:CLVT)
- Charles Schwab Investment Management Inc. grew its position in shares of Clarivate Plc (NYSE:CLVT – Free Report) by 3.3% in the fourth quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 4,645,333 shares of the company’s stock after buying an additional 149,573 shares during the quarter. Charles Schwab Investment Management Inc. owned 0.70% of Clarivate worth $43,016,000 as of its most recent filing with the SEC. Several other hedge funds also recently made changes to their positions in CLVT. Alaska Permanent Fund Corp lifted its holdings in shares of Clarivate by 0.9% in the 4th quarter. Alaska Permanent Fund Corp now owns 286,539 shares of the company’s stock valued at $2,653,000 after buying an additional 2,539 shares during the period. California Public Employees Retirement System lifted its holdings in Clarivate by 12.5% in the fourth quarter. California Public Employees Retirement System now owns 780,468 shares of the company’s stock valued at $7,227,000 after acquiring an additional 86,795 shares during the period. Handelsbanken Fonder AB boosted its position in shares of Clarivate by 103.8% during the 4th quarter. Handelsbanken Fonder AB now owns 127,600 shares of the company’s stock worth $1,182,000 after purchasing an additional 65,000 shares in the last quarter. Cerity Partners LLC acquired a new position in shares of Clarivate during the 4th quarter worth $956,000. Finally, Raymond James Financial Services Advisors Inc. increased its holdings in shares of Clarivate by 13.5% in the 4th quarter. Raymond James Financial Services Advisors Inc. now owns 23,032 shares of the company’s stock valued at $213,000 after purchasing an additional 2,743 shares in the last quarter. Institutional investors and hedge funds own 85.72% of the company’s stock. Wall Street Analyst Weigh In A number of brokerages have issued reports on CLVT. Oppenheimer dropped their target price on shares of Clarivate from $11.00 to $10.00 and set an “outperform” rating for the company in a report on Wednesday, February 28th. The Goldman Sachs Group decreased their price objective on shares of Clarivate from $8.50 to $7.50 and set a “buy” rating on the stock in a research report on Thursday, May 9th. Morgan Stanley cut their target price on shares of Clarivate from $9.00 to $8.00 and set an “equal weight” rating for the company in a research report on Wednesday, February 28th. Barclays dropped their price objective on shares of Clarivate from $7.00 to $6.00 and set an “underweight” rating for the company in a research note on Wednesday, February 28th. Finally, Royal Bank of Canada reduced their target price on Clarivate from $10.00 to $8.00 and set a “sector perform” rating on the stock in a research note on Wednesday, February 28th. Three equities research analysts have rated the stock with a sell rating, three have given a hold rating and three have issued a buy rating to the stock. Based on data from MarketBeat.com, the company currently has a consensus rating of “Hold” and an average price target of $7.78. Check Out Our Latest Analysis on CLVT Clarivate Stock Performance Clarivate stock opened at $6.01 on Monday. The company has a debt-to-equity ratio of 1.03, a current ratio of 0.86 and a quick ratio of 0.86. Clarivate Plc has a 12 month low of $5.99 and a 12 month high of $10.03. The company has a market cap of $4.02 billion, a price-to-earnings ratio of -3.62, a price-to-earnings-growth ratio of 1.50 and a beta of 1.24. The stock’s 50-day moving average is $7.03 and its 200-day moving average is $7.87. Clarivate (NYSE:CLVT – Get Free Report) last posted its quarterly earnings results on Tuesday, February 27th. The company reported $0.21 EPS for the quarter, meeting the consensus estimate of $0.21. Clarivate had a negative net margin of 39.29% and a positive return on equity of 10.11%. The firm had revenue of $683.70 million for the quarter, compared to analyst estimates of $687.80 million. During the same quarter last year, the firm posted $0.20 earnings per share. Clarivate’s revenue for the quarter was up 1.2% compared to the same quarter last year. Equities analysts anticipate that Clarivate Plc will post 0.62 earnings per share for the current year. About Clarivate (Free Report) Clarivate Plc operates as an information services provider in the Americas, the Middle East, Africa, Europe, and the Asia Pacific. It operates through three segments: Academia & Government, Life Sciences & Healthcare, and Intellectual Property. The company offers Web of Science and InCites, that analyzes and explores the academic research landscape and manages research information; ProQuest One and Ebook Central that provides comprehensive content collections to institutions in a cost-effective manner; and Alma and Polaris, that manages academic resources and services, connect users, and support research publications. See Also Five stocks we like better than Clarivate The Role Economic Reports Play in a Successful Investment Strategy MarketBeat Week in Review – 5/13 – 5/17 Investing in the High PE Growth Stocks Take-Two Interactive Software Offers 2nd Chance for Investors Are Penny Stocks a Good Fit for Your Portfolio? Deere & Company’s Q2 Report: Strong Revenue, Cautious Outlook
- 05/20/2024
|
Clarivate Launches AI-Enhanced Solution to Accelerate Trademark Watching
- Providing faster and more accurate answers to critical business questions LONDON , May 20, 2024 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT), a leading global provider of transformative intelligence, launched the first publicly available version of Trademark Watch Analyzer today at the 2024 International Trademark Association Annual Meeting. As the next-generation trademark protection solution enhanced by artificial intelligence (AI) and cloud technology, this solution combines Clarivate global trademark and case law data, in-house IP expertise, and cutting-edge AI technology.
- 05/20/2024
|
New Clarivate Report Reveals that the U.S., Germany and Mainland China have the most Non-Practicing Entity Litigation
- Infringement declined globally from 2012 to 2019 LONDON , May 16, 2024 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT), a leading global provider of transformative intelligence, today released the 2024 Non-Practicing Entity Global Litigation (NPE) Report to analyze NPE enforcement activities and their patent validity challenges across the globe. The report revealed that the United States, Germany and Mainland China are the three countries and regions with the most infringement cases filed by NPEs.
- 05/16/2024
|
OMRON Selects IPfolio from Clarivate
- IP solution maximizes operational efficiency for leading automation company LONDON , May 9, 2024 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT), a leading global provider of transformative intelligence, announced today that OMRON has selected IPfolio™, an intellectual property management software from Clarivate to transform their IP operations. This solution will enable OMRON, a leading automation company to make smarter decisions and plan strategically using IP data and analytical insights.
- 05/09/2024
|
Compared to Estimates, Clarivate (CLVT) Q1 Earnings: A Look at Key Metrics
- While the top- and bottom-line numbers for Clarivate (CLVT) give a sense of how the business performed in the quarter ended March 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
- 05/08/2024
|
Clarivate PLC (CLVT) Q1 Earnings Meet Estimates
- Clarivate PLC (CLVT) came out with quarterly earnings of $0.14 per share, in line with the Zacks Consensus Estimate. This compares to earnings of $0.18 per share a year ago.
- 05/08/2024
|
Clarivate Reports First Quarter 2024 Results
- — Reaffirms 2024 Outlook — LONDON , May 8, 2024 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT) (the "Company" or "Clarivate"), a leading global provider of transformative intelligence, today reported results for the first quarter ended March 31, 2024. First Quarter 2024 Financial Highlights Revenues of $621.2 million decreased 1.3% Organic revenues decreased 1.7%, as an increase in subscription revenues of 2.4% was more than offset by a decrease in transactional and other revenues of 11.4% and re-occurring revenues of 5.1% Net loss attributable to ordinary shares of $93.8 million; Net loss per diluted share of $0.14 Adjusted net income(1) of $103.5 million decreased 20.9%; Adjusted diluted EPS(1) of $0.14 decreased 22.2% or $0.04 Adjusted EBITDA(1) of $236.3 million decreased 6.5%; Adjusted EBITDA margin(1) of 38.0% decreased 220 basis points primarily due to lower revenues Net cash provided by operating activities of $176.2 million decreased $51.3 million; Free cash flow(1) of $111.8 million decreased $56.4 million primarily due to the timing of working capital "We are making great progress this year on key objectives including product investments and operational initiatives to drive future organic revenue growth," said Jonathan Gear, Chief Executive Officer.
- 05/08/2024
|
Clarivate Introduces Epidemiology Intelligence™ for Precision Patient Population Analysis
- Empowering biopharma with unified epidemiology, incidence and prevalence data alongside claims-based population insights, for precise market sizing and patient population analysis LONDON , May 7, 2024 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT), a leading global provider of transformative intelligence, today announced the launch of Epidemiology Intelligence™. The new solution combines rich insights from epidemiology, incidence and prevalence database solutions.
- 05/07/2024
|
Clarivate Enhances Cortellis CMC Intelligence with Post-Approval Module to Accelerate Regulatory Success
- Enhancements enable pharma, biotech and generics companies to streamline regulatory tracking and optimize life cycle management for small molecules and biologics LONDON , May 2, 2024 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT), a leading global provider of transformative intelligence, today announced the launch of the newly enhanced Cortellis CMC Intelligence™ solution, featuring a new post-approval variations module. The module for post-approval variations covers regulatory changes across multiple countries, offering meticulously curated requirements to streamline tracking.
- 05/02/2024
|
Clarivate Declares Dividend on Mandatory Convertible Preferred Shares
- LONDON , May 1, 2024 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT; CLVT PR A) ("Clarivate"), a leading global provider of transformative intelligence, today announced that its board of directors declared a quarterly dividend of $1.3125 per share on its 5.25% Series A Mandatory Convertible Preferred Shares (the "Preferred Shares"), payable in cash on June 3, 2024 to shareholders of record at the close of business on May 15, 2024. On the mandatory conversion date, which is scheduled to occur on June 3, 2024, each Preferred Share will automatically and mandatorily convert into a number of ordinary shares of Clarivate (and cash in lieu of any fractional ordinary shares) based on the average volume weighted average price ("VWAP") of Clarivate's ordinary shares over a 30-trading day period that begins on, and includes, April 18, 2024 and is scheduled to end on, and include, May 30, 2024 (the "valuation period").
- 05/01/2024
|
Clarivate PLC (CLVT) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
- Clarivate (CLVT) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
- 05/01/2024
|
BioWorld by Clarivate Explores the Future of CAR T Therapy in Mainland China in Special Report
- Three-part report investigates rapid pipeline growth, partnerships, clinical trials , and patient access challenges in cancer treatment LONDON , April 30, 2024 /PRNewswire/ -- BioWorld™ published by Clarivate Plc (NYSE:CLVT), a leading global provider of transformative intelligence, explores the growing investment in CAR T therapy development in mainland China in a new series titled " China's CAR T market comes of age." The report examines the dynamic realm of CAR T-cell therapies in China, including the rapid pipeline growth, deals, clinical trials and challenging issues surrounding patient access to very expensive and effective cancer therapeutics.
- 04/30/2024
|
Clarivate joins United Nations SDG Publishers Compact
- LONDON , April 24, 2024 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT), a leading global provider of transformative intelligence, today announces it has signed the United Nations Sustainable Development Goals (UN SDGs) Publishers Compact. Signatories of the compact pledge to develop sustainable practices and act as champions of the SDGs during the Decade of Action (2020-2030).
- 04/24/2024
|
Clarivate Acquires Global QMS, Inc., Expanding Life Sciences & Healthcare Segment into New Markets
- Acquisition supports critical client workflow and reporting needs with proprietary SaaS platform, automating regulatory report authoring and compliance across manufacturing operations, supply chain and quality management LONDON , April 23, 2024 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT) a leading global provider of transformative intelligence, today announced that it has acquired Global QMS, Inc., known as Global Q, a provider of cloud-based solutions that enable life sciences clients to automate regulatory reporting and compliance management. Financial terms of the transaction were not disclosed.
- 04/23/2024
|
Clarivate Launches LatAm Market Tracking Solution in Partnership with Global Healthcare Intelligence Enabling Real-Time Tracking of Medical Device Markets
- New solution offers comprehensive tracking and analysis of market share and size in Brazil, Colombia, Argentina, Chile, Peru and Ecuador LONDON , April 17, 2024 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT), a leading global provider of transformative intelligence, today released its LatAm market tracking solution, in collaboration with Global Healthcare Intelligence, a leading provider of market intelligence on healthcare infrastructure in frontier markets. The new solution is the next phase of an expanding partnership between Clarivate and Global Healthcare Intelligence, enabling in-depth and actionable analysis of the medical device market in Latin America (LatAm).
- 04/17/2024
|
Will Clarivate (CLVT) Beat Estimates Again in Its Next Earnings Report?
- Clarivate (CLVT) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
- 04/15/2024
|
Clarivate to Report First Quarter 2024 Results on May 8, 2024
- LONDON , April 15, 2024 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT), a leading global provider of transformative intelligence, announced today it will report its financial results for the first quarter before the market opens on Wednesday, May 8, 2024. The press release and earnings supplement, with accompanying financial information, will be available on the Clarivate investor website at https://ir.clarivate.com.
- 04/15/2024
|
Clarivate Leadership Presents at Recent Investor Conferences
- --- Clarivate CFO and Segment Presidents Discuss Growth Initiatives Including Generative AI Strategies --- LONDON , April 1, 2024 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT), a leading global provider of transformative intelligence, announced today that in conjunction with the recent launch of Clarivate in the Age of AI video webinar presentations, the Company's Chief Financial Officer and its three segment Presidents participated in panel discussions at investor conferences in March 2024. The recordings, which cover various topics including how Clarivate is leveraging content and solutions, incorporating Generative AI strategies and investing to realize its long-term growth potential, can be accessed as follows: March 7: Oppenheimer Capital Markets Tech and Analytics Virtual Bus Tour.
- 04/01/2024
|
Clarivate Acquires AI Start Up to Accelerate Strategy and Business Development Success for Life Sciences & Healthcare Clients
- Acquisition of MotionHall reinforces strategy to lead market-specific solutions, including workflows and expert services fuelled by industry vertical AI LONDON , March 21, 2024 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT) a leading global provider of transformative intelligence, has announced an agreement to acquire the substantial majority of assets of MotionHall, a Silicon Valley technology start-up company serving the life sciences with industry vertical artificial intelligence (AI) solutions. The asset purchase serves as a key component of the Clarivate™ Life Sciences & Healthcare strategy to deliver transformative intelligence through the application of generative AI (GenAI) and proprietary industry vertical AI solutions.
- 03/21/2024
|
New Webinar: Clarivate in the Age of AI - Driving Innovation in Intellectual Property Management and Decision Making
- --- Gordon Samson, President, Intellectual Property, Provides a Virtual Update on Strategy and Generative AI Initiatives --- LONDON , March 20, 2024 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT), a leading global provider of transformative intelligence, announced today the launch of the third and final video in a series of Clarivate in the Age of AI webinar presentations led by the Presidents of its three segments: Academia & Government, Life Sciences & Healthcare and Intellectual Property. The Intellectual Property (IP) video presentation highlights how Clarivate plays an important role in the IP ecosystem by serving as an indispensable partner to more than 20,000 customers.
- 03/20/2024
|
New Webinar: Clarivate in the Age of AI - Empowering Our Life Sciences & Healthcare Customers to Create a Healthier Tomorrow
- --- Henry Levy, President, Life Sciences & Healthcare, Provides a Virtual Update on Strategy and Generative AI Initiatives --- LONDON , March 13, 2024 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT), a leading global provider of transformative intelligence, announced today the launch of the second video in a series of Clarivate in the Age of AI webinar presentations led by the Presidents of its three segments: Academia & Government, Intellectual Property and Life Sciences & Healthcare. The Life Sciences & Healthcare video presentation highlights how Clarivate serves as an indispensable partner to our customers by providing solutions that enable mission critical decision making across the enterprise and the drug and medical device lifecycle.
- 03/13/2024
|
Clarivate to Present at the BofA Securities 2024 Information & Business Services Conference on March 14
- LONDON , March 7, 2024 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT), a leading global provider of transformative intelligence, announced today that Jonathan Collins, Executive Vice President and Chief Financial Officer, and Henry Levy, President, Life Sciences & Healthcare, will present at the BofA Securities 2024 Information & Business Services Conference on Thursday, March 14, 2024 at 3:35 pm Eastern Time. The live webcast can be accessed at https://bofa.veracast.com/webcasts/bofa/infoservices2024/id8q5vjH.cfm and will be available for replay.
- 03/07/2024
|
Clarivate Plc (CLVT) Q4 2023 Earnings Call Transcript
- Clarivate Plc (CLVT) Q4 2023 Earnings Call Transcript
- 03/01/2024
|
Clarivate PLC (CLVT) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates
- The headline numbers for Clarivate PLC (CLVT) give insight into how the company performed in the quarter ended December 2023, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
- 02/27/2024
|
Countdown to Clarivate PLC (CLVT) Q4 Earnings: A Look at Estimates Beyond Revenue and EPS
- Evaluate the expected performance of Clarivate PLC (CLVT) for the quarter ended December 2023, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight.
- 02/22/2024
|
Clarivate: Rating Upgrade As Organic Growth Turns Positive
- Clarivate has turned organic growth positive and has visible tailwinds that could drive organic growth higher. The company reported positive organic growth in 3Q23, beating consensus estimates for revenue and EBITDA margins. The A&G and LSH segments showed strong organic growth, and the IP segment is expected to recover as macro headwinds ease.
- 12/17/2023
|
Clarivate Plc (CLVT) Q3 2023 Earnings Call Transcript
- Clarivate Plc (NYSE:CLVT ) Q3 2023 Earnings Conference Call November 7, 2023 9:00 AM ET Company Participants Mark Donohue - Vice President, Investor Relations Jonathan Gear - Chief Executive Officer Jonathan Collins - Executive Vice President and Chief Financial Officer Conference Call Participants Toni Kaplan - Morgan Stanley Manav Patnaik - Barclays Surinder Thind - Jefferies Andrew Nicholas - William Blair John Mazzoni - Wells Fargo Owen Lau - Oppenheimer Ashish Sabadra - RBC Capital Markets Peter Christiansen - Citi George Tong - Goldman Sachs Operator Good morning. Thank you for attending today's Clarivate Third Quarter 2023 Earnings Call.
- 11/07/2023
|
Clarivate PLC (CLVT) Beats Q3 Earnings and Revenue Estimates
- Clarivate PLC (CLVT) came out with quarterly earnings of $0.21 per share, beating the Zacks Consensus Estimate of $0.18 per share. This compares to earnings of $0.20 per share a year ago.
- 11/07/2023
|
EBAY Gears Up to Report Q3 Earnings: What's in the Offing?
- EBAY's third-quarter 2023 results are likely to reflect the impacts of strong momentum across Promoted Listings amid softness in the marketplace platform.
- 11/06/2023
|
Will Clarivate PLC (CLVT) Beat Estimates Again in Its Next Earnings Report?
- Clarivate PLC (CLVT) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
- 10/23/2023
|
Clarivate Plc (CLVT) Q2 2023 Earnings Call Transcript
- Clarivate Plc (NYSE:CLVT ) Q2 2023 Earnings Conference Call August 3, 2023 9:00 AM ET Company Participants Mark Donohue - Vice President, Investor Relations Jonathan Gear - Chief Executive Officer Jonathan Collins - Executive Vice President and Chief Financial Officer Conference Call Participants Manav Patnaik - Barclays Toni Kaplan - Morgan Stanley Ashish Sabadra - RBC Capital Markets Andrew Nicholas - William Blair Hans Hoffman - Jefferies Owen Lau - Oppenheimer Seth Weber - Wells Fargo Peter Christiansen - Citi George Tong - Goldman Sachs Operator Hello, everyone, and welcome to the Clarivate Second Quarter 2023 Earnings Conference Call. My name is Nadia, and I'll be coordinating the call today.
- 08/06/2023
|
Clarivate PLC (CLVT) Reports Q2 Earnings: What Key Metrics Have to Say
- Although the revenue and EPS for Clarivate PLC (CLVT) give a sense of how its business performed in the quarter ended June 2023, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
- 08/03/2023
|
Clarivate to Report Second Quarter 2023 Results on August 3, 2023
- LONDON , July 7, 2023 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT), a global leader in connecting people and organizations to intelligence they can trust to transform their world, announced today it will report its financial results for the second quarter 2023 before the market opens on Thursday, August 3. The press release and earnings supplement, with accompanying financial information, will be posted on the Clarivate investor website.
- 07/07/2023
|
CLVT or FFIV: Which Is the Better Value Stock Right Now?
- Investors with an interest in Internet - Software stocks have likely encountered both Clarivate PLC (CLVT) and F5 Networks (FFIV). But which of these two stocks presents investors with the better value opportunity right now?
- 06/26/2023
|
Invest in 5 Top Stocks Set to Exceed Earnings Estimates
- These top-ranked stocks are likely to beat on the bottom line in their next releases. Tap Clorox (CLX), Wingstop (WING), Tri Pointe Homes (TPH), Clarivate (CLVT) and SPX Technologies Inc. (SPXC) for gains.
- 06/15/2023
|
CLVT vs. INFA: Which Stock Is the Better Value Option?
- Investors looking for stocks in the Internet - Software sector might want to consider either Clarivate PLC (CLVT) or Informatica Inc. (INFA). But which of these two stocks presents investors with the better value opportunity right now?
- 06/09/2023
|
Wall Street Analysts Predict a 54.5% Upside in Clarivate PLC (CLVT): Here's What You Should Know
- The average of price targets set by Wall Street analysts indicates a potential upside of 54.5% in Clarivate PLC (CLVT). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
- 06/02/2023
|
Clarivate to Present at Upcoming Investor Conferences in June 2023
- LONDON , May 31, 2023 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT) (the "Company" or "Clarivate"), a global leader in connecting people and organizations to intelligence they can trust to transform their world, announced today that the Company will present at the following investor conferences in June 2023. Jonathan Gear, Chief Executive Officer, will present at the William Blair Growth Stock Conference on Tuesday, June 6, 2023 at 3:20 pm Central Time (4:20 pm Eastern Time).
- 05/31/2023
|
CLVT vs. INFA: Which Stock Should Value Investors Buy Now?
- Investors looking for stocks in the Internet - Software sector might want to consider either Clarivate PLC (CLVT) or Informatica Inc. (INFA). But which of these two stocks offers value investors a better bang for their buck right now?
- 05/24/2023
|
Clarivate PLC (CLVT) Q1 2023 Earnings Call Transcript
- Clarivate PLC (NYSE:CLVT ) Q1 2023 Earnings Conference Call May 9, 2023 9:00 AM ET Company Participants Mark Donohue - Head of Investor Relations Jonathan Gear - Chief Executive Officer & Director Jonathan Collins - Executive Vice President & Chief Financial Officer Conference Call Participants George Tong - Goldman Sachs Group Thomas Roesch - William Blair Toni Kaplan - Morgan Stanley Peter Christiansen - Citigroup Seth Weber - Wells Fargo Securities Adam Parrington - Stifel Stephanie Moore - Jefferies Operator Good morning. Thank you for attending today's Clarivate Q1 2023 Earnings Conference Call.
- 05/14/2023
|
Clarivate PLC (CLVT) Q1 Earnings and Revenues Top Estimates
- Clarivate PLC (CLVT) came out with quarterly earnings of $0.18 per share, beating the Zacks Consensus Estimate of $0.15 per share. This compares to earnings of $0.21 per share a year ago.
- 05/09/2023
|
Impactive takes a stake in Clarivate and sets the tone for activism in the post-SPAC world
- Impactive's latest engagement with Clarivate shows how activists can seek potential in fallen SPAC stocks.
- 05/06/2023
|
Will Clarivate PLC (CLVT) Beat Estimates Again in Its Next Earnings Report?
- Clarivate PLC (CLVT) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
- 04/17/2023
|
Clarivate: A Great Recovery Play
- Clarivate has plummeted over 70% from its all-time high. The business has been messy but the new management team is now cleaning things up and the fundamentals remain solid.
- 04/07/2023
|
Clarivate: Challenges To Deliver High Growth
- The CLVT business is widely adopted in the industry and has proven to be enduring and difficult to replace. CLVT should be relatively recession-proof given its mission-critical solutions and the customer base.
- 04/06/2023
|
Clarivate to Present at the BofA Securities 2023 Information & Business Services Conference on March 16
- LONDON , March 13, 2023 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT), a global leader in connecting people and organizations to intelligence they can trust, announced today that Jonathan Collins, Executive Vice President and Chief Financial Officer, will present at the BofA Securities 2023 Information & Business Services Conference on Thursday, March 16, 2023 at 9:45 am Eastern Time. The live webcast can be accessed at https://bofa.veracast.com/webcasts/bofa/infoservices2023/idso9130.cfm and will be available for replay.
- 03/13/2023
|
Clarivate PLC (CLVT) Q4 2022 Earnings Call Transcript
- Clarivate PLC (NYSE:CLVT ) Q4 2022 Earnings Conference Call March 1, 2023 9:00 AM ET Company Participants Mark Donohue - Head, IR Jonathan Gear - CEO & Director Jonathan Collins - EVP & CFO Conference Call Participants George Tong - Goldman Sachs Group Toni Kaplan - Morgan Stanley Seth Weber - Wells Fargo Securities John Mazzoni - RBC Capital Markets Stephanie Moore - Jefferies Adam Parrington - Stifel, Nicolaus & Company Peter Christiansen - Citigroup Operator Hello, and welcome to today's Clarivate Q4 and Full Year Earnings Conference Call. My name is Bailey, and I'll be the moderator for today's call.
- 03/01/2023
|
Clarivate PLC (CLVT) Q4 Earnings and Revenues Top Estimates
- Clarivate PLC (CLVT) delivered earnings and revenue surprises of 29.41% and 3.67%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
- 03/01/2023
|
Clarivate PLC (CLVT) Upgraded to Strong Buy: Here's What You Should Know
- Clarivate PLC (CLVT) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
- 02/10/2023
|
New Strong Buy Stocks for February 10th
- SNEX, DTEGY, CLVT, HAE and ARCC have been added to the Zacks Rank #1 (Strong Buy) List on February 10, 2022.
- 02/10/2023
|
Is Clarivate (CLVT) Outperforming Other Computer and Technology Stocks This Year?
- Here is how Clarivate PLC (CLVT) and Lyft (LYFT) have performed compared to their sector so far this year.
- 02/07/2023
|
Clarivate to Report Fourth Quarter and Full Year 2022 Results on March 1, 2023
- LONDON , Feb. 7, 2023 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT), a global leader in connecting people and organizations to intelligence they can trust to transform their world, announced today it will report its financial results for the fourth quarter and full year 2022 before the market opens on Wednesday, March 1. The press release and earnings supplement, with accompanying financial information, will be posted on the Clarivate investor website at https://ir.clarivate.com.
- 02/07/2023
|
Time to Buy these Top-Rated Growth Stocks at a Discount?
- These three stocks have seen stellar EPS growth over the last five years and their attractive valuations make them appear to have more short-term upside in addition to being solid long-term investments.
- 01/25/2023
|
Time To Pick These 3 Top Relative Price Strength Stocks
- Clarivate Plc (CLVT), Expedia Group (EXPE) and Haemonetics Corporation (HAE) are three stocks with explosive relative price strength.
- 01/24/2023
|
Wall Street Books Best Week Since November: 5 Growth Picks
- The stock market gains momentum as consumer sentiment improves on fading inflation. Thus, invest in growth players like AMN Healthcare Services (AMN), Clarivate (CLVT), Core & Main (CNM), CRH & Deere (DE) for solid returns.
- 01/16/2023
|
Is the Options Market Predicting a Spike in Clarivate (CLVT) Stock?
- Investors need to pay close attention to Clarivate (CLVT) stock based on the movements in the options market lately.
- 11/16/2022
|
Clarivate PLC (CLVT) Q3 2022 Earnings Call Transcript
- Clarivate PLC (NYSE:CLVT ) Q3 2022 Earnings Conference Call November 8, 2022 9:00 AM ET Company Participants Mark Donohue - Head, IR Jonathan Gear - CEO & Director Jonathan Collins - EVP & CFO Conference Call Participants Manav Patnaik - Barclays Bank Toni Kaplan - Morgan Stanley Andrew Nicholas - William Blair & Company Shlomo Rosenbaum - Stifel Seth Weber - Wells Fargo Securities John Mazzoni - RBC Capital Markets Hans Hoffman - Jefferies Peter Christiansen - Citi George Tong - Goldman Sachs Operator Good morning. Thank you for attending today's Clarivate Q3 2022 Earnings Release Call.
- 11/12/2022
|
Clarivate PLC (CLVT) Q3 Earnings Beat Estimates
- Clarivate PLC (CLVT) delivered earnings and revenue surprises of 17.65% and 1.20%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
- 11/08/2022
|
Clarivate to Report Third Quarter 2022 Results on November 8, 2022
- Announces plans for Investor Day in 2023 LONDON , Sept. 28, 2022 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT), a global leader in providing trusted information and insights to accelerate the pace of innovation, announced today it will report its financial results for the third quarter 2022 before the market opens on Tuesday, November 8.
- 09/28/2022
|
Is the Options Market Predicting a Spike in Clarivate (CLVT) Stock?
- Investors need to pay close attention to Clarivate (CLVT) stock based on the movements in the options market lately.
- 09/07/2022
|
Clarivate Plc (CLVT) CEO Jerre Stead on Q2 2022 Results - Earnings Call Transcript
- Clarivate Plc (NYSE:CLVT ) Q2 2022 Earnings Conference Call August 9, 2022 9:00 AM ET Company Participants Mark Donohue - Head of IR Jerre Stead - Executive Chair & CEO Jonathan Gear - CEO Jonathan Collins - CFO Gordon Samson - Chief Product Officer Steen Lomholt-Thomsen - Chief Revenue Officer Conference Call Participants Manav Patnaik - Barclays George Tong - Goldman Sachs Hans Hoffman - Jefferies Ashish Sabadra - RBC Capital Markets Trevor Romeo - William Blair Toni Kaplan - Morgan Stanley Operator Good morning. Thank you for attending today's Clarivate Second Quarter 2022 Earnings Conference.
- 08/12/2022
|
Clarivate PLC (CLVT) Surpasses Q2 Earnings Estimates
- Clarivate PLC (CLVT) delivered earnings and revenue surprises of 4.76% and 0.71%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
- 08/09/2022
|
Clarivate to Report Second Quarter 2022 Results on August 9, 2022
- LONDON , July 7, 2022 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT), a global leader in providing trusted information and insights to accelerate the pace of innovation, announced today it will report its financial results for the second quarter 2022 before the market opens on Tuesday, August 9. The press release and earnings supplement, with accompanying financial information, will be posted on the Clarivate investor website at https://ir.clarivate.com.
- 07/07/2022
|
Clarivate Plc (CLVT) CEO Jerre Stead on Q1 2022 Results - Earnings Call Transcript
- Clarivate Plc (NYSE:CLVT ) Q1 2022 Earnings Conference Call May 9, 2022 9:00 AM ET Company Participants Mark Donohue - Head of Investor Relations Jerre Stead - Executive Chair & Chief Executive Officer Jonathan Collins - Chief Financial Officer Gordon Samson - Chief Product Officer Steen Lomholt-Thomsen - Chief Revenue Officer Conference Call Participants Toni Kaplan - Morgan Stanley George Tong - Goldman Sachs Andrew Nicholas - William Blair Ashish Sabadra - RBC Capital Markets Hamzah Mazari - Jefferies Shlomo Rosenbaum - Stifel Pete Christiansen - Citi Operator Hello and welcome to today's Clarivate First Quarter 2022 Earnings Conference Call. My name is Bailey and I will be your moderator for today's call.
- 05/09/2022
|
Clarivate PLC (CLVT) Q1 Earnings Top Estimates
- Clarivate PLC (CLVT) delivered earnings and revenue surprises of 10.53% and 2.05%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
- 05/09/2022
|
7 Stocks to Buy Giving Russia the Cold Shoulder
- A total of 165 companies are exiting Russia or suspending operations. Here are seven stocks to buy are leaving completely due to the war.
- 03/23/2022
|
Clarivate to Present at the Bank of America 2022 Information Services Conference on March 17
- LONDON, March 11, 2022 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT), a global leader in providing trusted information and insights to accelerate the pace of innovation, announced today that Jerre Stead, Executive Chair and Chief Executive Officer, and Jonathan Collins, Chief Financial Officer, will present at the Bank of America 2022 Information Service Conference on Thursday, March 17, 2022 at 8:55 AM Eastern Time. A live webcast of the event will be available on the Investor Relations section of the Clarivate website at http://ir.clarivate.com/Event-Calendar.
- 03/11/2022
|
Clarivate Plc (CLVT) CEO Jerre Stead on Q4 2021 Results - Earnings Call Transcript
- Clarivate Plc (CLVT) CEO Jerre Stead on Q4 2021 Results - Earnings Call Transcript
- 03/10/2022
|
Why Clarivate Stock Jumped Today
- Strong quarterly results propelled this tech stock higher.
- 03/10/2022
|
Clarivate PLC (CLVT) Q4 Earnings and Revenues Surpass Estimates
- Clarivate PLC (CLVT) delivered earnings and revenue surprises of 4.55% and 0.13%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?
- 03/10/2022
|
Down 10.6% in 4 Weeks, Here's Why You Should You Buy the Dip in Clarivate PLC (CLVT)
- Clarivate PLC (CLVT) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.
- 03/07/2022
|
Why Clarivate (CLVT) Might Surprise This Earnings Season
- Clarivate (CLVT) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
- 03/07/2022
|
Clarivate PLC (CLVT) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
- Clarivate PLC (CLVT) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
- 03/03/2022
|
Bears are Losing Control Over Clarivate PLC (CLVT), Here's Why It's a 'Buy' Now
- Clarivate PLC (CLVT) appears to have found support after losing some value lately, as indicated by the formation of a hammer chart. In addition to this technical chart pattern, strong agreement among Wall Street analysts in revising earnings estimates higher enhances the stock's potential for a turnaround in the near term.
- 03/03/2022
|
Down 32.8% in 4 Weeks, Here's Why You Should You Buy the Dip in Clarivate PLC (CLVT)
- The heavy selling pressure might have exhausted for Clarivate PLC (CLVT) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.
- 02/01/2022
|
Clarivate PLC (CLVT) Upgraded to Buy: Here's Why
- Clarivate PLC (CLVT) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
- 01/26/2022
|
2 Stocks every investor should consider shorting this week
- We have identified names that look bearish and may present interesting investing opportunities on the short side. Using technical analysis of the charts of those stocks and appropriate recent actions, we have zeroed in on 2 names.
- 01/24/2022
|
Clarivate Stock (CLVT): $30 Price Target From Goldman Sachs
- The shares of Clarivate Plc (NYSE: CLVT) have received a $30 price target from Goldman Sachs. These are the details.
- 12/14/2021
|
Clarivate (CLVT) Stock: Why The Price Jumped Today
- The stock price of Clarivate (NYSE: CLVT) increased by over 11% during intraday trading today. This is why it happened.
- 12/02/2021
|
Clarivate to Present at Upcoming Investor Conferences in November and December 2021
- LONDON, Nov. 24, 2021 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT), a global leader in providing trusted information and insights to accelerate the pace of innovation, announced today that Jerre Stead, Executive Chairman and Chief Executive Officer, and Richard Hanks, Chief Financial Officer, will present at the following virtual investor conferences in November and December 2021. BofA Securities Leveraged Finance Conference 2021 on Tuesday, November 30, 2021 at 8:15 am Eastern Time.
- 11/24/2021
|
Clarivate to Present at Upcoming Investor Conferences in November 2021
- LONDON, Nov. 12, 2021 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT), a global leader in providing trusted information and insights to accelerate the pace of innovation, announced today that Jerre Stead, Executive Chairman and Chief Executive Officer, and Richard Hanks, Chief Financial Officer, will present at the following virtual investor conferences in November 2021. RBC Capital Markets Global Technology, Internet, Media and Telecom Virtual Conference on Wednesday, November 17, 2021 at 9:35 am Eastern Time.
- 11/12/2021
|
Clarivate Plc (CLVT) CEO Jerre Stead on Q3 2021 Results - Earnings Call Transcript
- Clarivate Plc (CLVT) CEO Jerre Stead on Q3 2021 Results - Earnings Call Transcript
- 10/28/2021
|
Clarivate Measures Research Performance of the World's Leading Economies in Annual G20 Scorecard Report
- Web of Science data uncovers links between G20 nations' response to COVID-19 and research subject diversity LONDON, Oct. 19, 2021 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT), a global leader in providing trusted information and insights to accelerate the pace of innovation, today launched a new report which examines the research performance of each of the member countries of the G20 with a visual comparative snapshot for each nation. It also includes a special analysis of the G20 members' COVID-19 research as indexed in the Web of Science™ research publication and citation index.
- 10/19/2021
|
Clarivate Demonstrates 2021 Nobel Prediction Success in Every Field of Science and Economics
- 64 researchers named as 'Citation Laureates' have received Nobel honors since 2002 LONDON, Oct. 13, 2021 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT), a global leader in providing trusted information and insights to accelerate the pace of innovation, today celebrates the five new Nobel Laureates across the fields of science and economics who were accurately identified as potential Nobel Prize recipients. Each individual was awarded the designation of Citation Laureate™ as much as 12 years prior to being named by the Nobel Assembly.
- 10/13/2021
|
Clarivate to Report Third Quarter 2021 Results on October 28, 2021
- LONDON, Sept. 30, 2021 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT), a global leader in providing trusted information and insights to accelerate the pace of innovation, announced today it will report its financial results for the third quarter 2021 before the market opens on Thursday, October 28.
- 09/30/2021
|
Clarivate Global Research Report Outlines Rising Impact in Latin America
- New data on research landscape of 34 countries across South & Central America, Mexico and the Caribbean highlights benefits of an EU-style regional collaborative research organization LONDON, Sept. 30, 2021 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT), a global leader in providing trusted information and insights to accelerate the pace of innovation, today released a report which examines the research landscape of a diverse region of 34 countries, across South and Central America, Mexico and the islands of the Caribbean, over four decades since 1981.
- 09/30/2021
|
Clarivate Unveils Citation Laureates 2021 - Annual List of Researchers of Nobel Class
- LONDON, Sept. 22, 2021 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT), a global leader in providing trusted information and insights to accelerate the pace of innovation, today named 16 world-class researchers from six countries as Citation Laureates™.
- 09/22/2021
|
2021 Centre for Medicines Research (CMR) Pharmaceutical R&D Factbook from Clarivate Finds Drug Approvals at a 10-year High Despite the Challenges of COVID-19
- LONDON, Sept. 15, 2021 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT), a global leader in providing trusted information and insights to accelerate the pace of innovation, today announced the release of the 2021 Centre for Medicines Research (CMR) International Pharmaceutical R&D Factbook.
- 09/15/2021
|
Clarivate Announces Winner of Eugene Garfield Award 2021
- Elena Pallari receives $25,000 for proposal for innovation in clinical research assessment LONDON, Sept. 13, 2021 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT), a global leader in providing trusted information and insights to accelerate the pace of innovation, today named Elena Pallari, Department of Clinical Trials and Methodology, University College London, U.K., as the recipient of the 2021 Eugene Garfield Award for Innovation in Citation Analysis.
- 09/13/2021
|
Clarivate Announces Pricing of Secondary Ordinary Share Offering
- LONDON, Sept. 10, 2021 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT) (the "Company" or "Clarivate") announced today that affiliated funds of Onex Corporation ("Onex") (TSX: ONEX) and Baring Private Equity Asia Group Ltd ("BPEA") (together, the "Selling Shareholders") have priced an underwritten public offering of an aggregate of 25,000,000 ordinary shares of the Company.
- 09/10/2021
|
Clarivate Announces Secondary Ordinary Share Offering
- LONDON, Sept. 9, 2021 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT) (the "Company" or "Clarivate") announced today that affiliated funds of Onex Corporation ("Onex") (TSX: ONEX) and Baring Private Equity Asia Group Ltd ("BPEA") (together, the "Selling Shareholders") intend to offer an aggregate of 25,000,000 ordinary shares of the Company in an underwritten public offering, subject to market conditions.
- 09/09/2021
|
Clarivate to Present at the Barclays Global Financial Services Conference on September 15, 2021
- LONDON, Sept. 8, 2021 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT), a global leader in providing trusted information and insights to accelerate the pace of innovation, announced today that Jerre Stead, Executive Chairman and Chief Executive Officer, and Richard Hanks, Chief Financial Officer, will present at the Barclays Global Financial Services Conference on Wednesday, September 15, 2021 at 11:15 AM Eastern Time.
- 09/08/2021
|
Clarivate Announces Settlement of Private Exchange Offers and Redemption of Untendered Notes
- LONDON, Aug. 19, 2021 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT) (the "Company" or "Clarivate"), a global leader in providing trusted information and insights to accelerate the pace of innovation, announced the settlement of the previously announced private offers to exchange (the "Exchange Offers"), by Clarivate Science Holdings Corporation, its indirect wholly owned subsidiary ("CSHC"), any and all of its outstanding 3.875% Senior Secured Notes due 2028 (the "Old Secured Notes") and 4.875% Senior Notes due 2029 (the "Old Unsecured Notes" and, together with the Old Secured Notes, the "Old Notes") for two new series of CSHC's senior notes (collectively, the "New Notes"). On August 19, 2021 (the "Settlement Date"), CSHC accepted tenders from holders of $921,177,000 aggregate principal amount of Old Secured Notes and $921,399,000 aggregate principal amount of Old Unsecured Notes.
- 08/19/2021
|
Clarivate Announces Expiration of its Private Exchange Offers for Two Series of Notes
- LONDON, Aug. 16, 2021 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT) (the "Company" or "Clarivate"), a global leader in providing trusted information and insights to accelerate the pace of innovation, announced the expiration of two separate private offers to exchange (the "Exchange Offers"), by Clarivate Science Holdings Corporation, its indirect wholly owned subsidiary ("CSHC"), any and all of the outstanding notes listed in the table below (collectively, the "Old Notes") for two new series of CSHC's senior notes (collectively, the "New Notes"). The Old Notes, which contain a provision requiring Clarivate to redeem such notes if its previously announced acquisition of ProQuest has not been consummated on or before November 8, 2021, are being exchanged for New Notes which extend such end date to April 29, 2022, among other changes, on the terms and subject to the conditions set forth in the Offering Memorandum dated August 9, 2021 (the "Offering Memorandum" and, together with the eligibility letter and the notice of guaranteed delivery, the "Exchange Offer Documents").
- 08/16/2021
|
Clarivate Acquires Bioinfogate, Reinforcing Position as Premier Provider of End-to-End Research Intelligence Solutions for Life Sciences
- Expanding and integrating drug toxicity data and translational safety intelligence from OFF-X into all aspects of the life science cycle, allowing customers to make more informed decisions LONDON, Aug. 4, 2021 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT), a global leader in providing trusted information and insights to accelerate the pace of innovation, today announced that it has acquired Bioinfogate, a leading provider of analytics solutions in the life sciences and producer of the OFF-X™ portal. Financial terms of the transaction were not disclosed.
- 08/04/2021
|
Clarivate Announces $250 Million Share Repurchase Program
- LONDON, Aug. 3, 2021 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT; CLVT PR A), a global leader in providing trusted information and insights to accelerate the pace of innovation, today announced that its Board of Directors has approved the purchase of up to $250 million of the Company's ordinary shares through open-market purchases, to be executed through October 31, 2021. "Our Board is confident in both our short and long-term growth prospects and believes repurchasing our shares represents an attractive investment opportunity," said Jerre Stead, Executive Chairman and CEO.
- 08/03/2021
|
Clarivate Plc (CLVT) CEO Jerre Stead on Q2 2021 Results - Earnings Call Transcript
- Clarivate Plc (CLVT) CEO Jerre Stead on Q2 2021 Results - Earnings Call Transcript
- 07/31/2021
|
Clarivate Stock Falls After In-line Q2 Earnings, Trimmed FY21 EPS Outlook
- Clarivate PLC (NYSE: CLVT) reported second-quarter revenue growth of 61.4% year-over-year to $447 million (up 5% on an organic basis), beating the consensus of $435.24 million. Revenues from Subscription increased 12.5% Y/Y to $243.6 million, driven by the acquisition of CPA Global, Re-occurring revenues were $113.7 million, and Transactional increased 48.7% Y/Y to $89.8 million.
- 07/29/2021
|
Clarivate PLC (CLVT) Q2 Earnings Lag Estimates
- Clarivate PLC (CLVT) delivered earnings and revenue surprises of -5.56% and 3.69%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?
- 07/29/2021
|
Clarivate: Q2 Earnings Insights
- Shares of Clarivate (NYSE:CLVT) remained unaffected after the company reported Q2 results. Quarterly Results Earnings per share decreased 5.56% year over year to $0.17, which were in line with the estimate of $0.17.
- 07/29/2021
|
Clarivate Reports Second Quarter 2021 Results
- LONDON, July 29, 2021 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT) (the "Company" or "Clarivate"), a global leader in providing trusted information and insights to accelerate the pace of innovation, today reported results for the second quarter ended June 30, 2021. Second Quarter 2021 Financial Highlights Revenues of $445.6 million and Adjusted Revenues(1) of $447.0 million, increased 59% and 57%, respectively, at constant currency Organic revenues(1), which exclude the impact of acquisitions and divestitures, increased 5%, at constant currency Net loss of $82.2 million increased 225%; Adjusted Net Income(1) of $110.0 million increased 58% Net loss per diluted share of $(0.13) increased $0.06; Adjusted Income per diluted share(1) (EPS) of $0.17 decreased $0.01 due to a 63% increase in the weighted average ordinary shares outstanding driven primarily by the CPA Global acquisition and the Company's 1H 2020 primary and secondary offerings, which have now been outstanding for a full period Adjusted EBITDA(1) of $189.0 million increased 89% and Adjusted EBITDA Margin(1) of 42% increased 610 basis points First Half 2021 Financial Highlights Revenue of $874.1 million and Adjusted Revenue(1) of $878.5 million increased 66% and 65%, respectively, at constant currency Organic revenues([1]), which exclude the impact of acquisitions and divestitures, increased 6%, at constant currency Net loss of $106.2 million decreased 32%; Adjusted Net Income(1) of $198.4 million increased 109% Net loss per diluted share of $(0.17) decreased 60% or $(0.26); Adjusted Income per diluted share(1) (EPS) of $0.31 increased 24% or $0.06 Adjusted EBITDA(1) of $353.8 million increased 98% and Adjusted EBITDA Margin(1) of 40% increased 600 basis points Cash Flow from Operations increased $154 million to $262 million; Adjusted Free Cash Flow(1) increased $138.9 million to $258.5 million ________________________________ 1 Represents a Non-GAAP measure.
- 07/29/2021
|
Clarivate Introduces Cortellis Supply Chain Network™, a Revolutionary Digital Partnering Solution
- LONDON, July 21, 2021 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT), a global leader in providing trusted information and insights to accelerate the pace of innovation, today announced the launch of the Cortellis Supply Chain Network™, a part of the Cortellis suite of life science intelligence solutions. The solution supports generics companies, Active Pharmaceutical Ingredients (API) manufacturers, fine chemical manufacturers, excipient manufacturers, raw materials suppliers, and biopharma in their pursuit to maintain a steady supply chain -- ultimately making therapies easily accessible to all patients.
- 07/21/2021
|
Clarivate Declares Dividend on Mandatory Convertible Preferred Stock
- LONDON, July 16, 2021 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT; CLVT PR A), a global leader in providing trusted information and insights to accelerate the pace of innovation, today announced that its board of directors declared a quarterly dividend of approximately $1.12 per share on its 5.25% Series A Mandatory Convertible Preferred Shares, payable on September 1, 2021 to shareholders of record at the close of business on August 15, 2021. As permitted by the Statement of Rights governing its 5.25% Series A Mandatory Convertible Preferred Shares, such dividend will be payable solely by delivery of ordinary shares (other than cash in lieu of any fractional ordinary share).
- 07/16/2021
|
SID Reports Significant 'Impact Factor' Increase for Flagship Publication
- CAMPBELL, Calif., July 14, 2021 /PRNewswire/ -- The Society for Information Display (SID) has announced that SID's flagship publication, the Journal of the Society for Information Display (JSID), now has an Impact Factor of 2.140, a substantial increase from previous years.
- 07/14/2021
|
Clarivate Integrates Trademark Solutions to Unlock the Full Value of Customers' IP
- Reducing manual data entry efforts to help customers save time and increase data quality LONDON, July 14, 2021 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT), a global leader in providing trusted information and insights to accelerate the pace of innovation, today announced the integration of its trademark research and protection solutions powered by CompuMark™ into IPfolio™ and FoundationIP™, IP management software (IPMS) solutions for corporations and law firms. This integration is part of a long-term strategy by Clarivate to remove friction from IP management processes by connecting the IP ecosystem.
- 07/14/2021
|
New Clarivate Report Identifies Battery Capacity and Charging Technologies as Key to Accelerating Electric Vehicle Adoption
- State of innovation in electric vehicles, design challenges and opportunities uncovered by combining the power of unified IP with global research data insights LONDON, July 8, 2021 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT), a global leader in providing trusted information and insights to accelerate the pace of innovation, today released a new report, The road ahead: sustainable vehicles today and in the future , that reveals the state of innovation in electric vehicles (EVs), the changing competitive landscape and geographic trends. Despite impressive strides in innovation in the last two decades, vehicle charge time and battery capacity are unsolved, critical design issues and overcoming them is vital to unlocking the market potential for electric vehicles.
- 07/08/2021
|
Clarivate Launches New Web of Science to Accelerate the Pace of Research and Discovery
- LONDON, July 7, 2021 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT), a global leader in providing trusted information and insights to accelerate the pace of innovation, today unveiled significant enhancements to the Web of Science™ offering researchers a highly dynamic, personal and indispensable research assistant through a host of new features and a redesigned user interface. The Web of Science is the world's most trusted publisher-independent global citation database, home to an unrivalled breadth of world-class research literature linked to a rigorously selected core of journals.
- 07/07/2021
|
Clarivate Announces Changes to Executive Leadership Team and Adds Chief Revenue Officer
- LONDON, July 6, 2021 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT), a global leader in providing trusted information and insights to accelerate the pace of innovation, today announced important changes to its senior leadership team and is pleased to welcome two new executives to the company. Steen Lomholt-Thomsen will join on August 2 in the newly created position of Chief Revenue Officer and Jaspal (Jas) Chahal joins today as Chief Legal Officer and General Counsel.
- 07/06/2021
|
Clarivate to Report Second Quarter 2021 Results on July 29, 2021
- LONDON, July 2, 2021 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT), a global leader in providing trusted information and insights to accelerate the pace of innovation, announced today it will report its financial results for the second quarter 2021 before the market opens on Thursday, July 29. The press release and earnings supplement, with accompanying financial information, will be posted on the Clarivate investor website at https://ir.clarivate.com.
- 07/02/2021
|
Clarivate Releases Journal Citation Reports, Naming the World's Leading Journals
- 2021 launch delivers expanded content, new Journal Citation Indicator and revamped user interface LONDON , June 30, 2021 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT), a global leader in providing trusted information and insights to accelerate the pace of innovation, today released the 2021 update to its annual Journal Citation Reports (JCR)™. The annual JCR release enables the research community to evaluate the world's high-quality academic journals using a range of indicators, descriptive data and visualizations.
- 06/30/2021
|
New Preferred Stock IPOs, June 2021
- New Preferred Stock IPOs, June 2021
- 06/30/2021
|
Clarivate: ProQuest Acquisition Accelerates The Compounding Potential
- Clarivate: ProQuest Acquisition Accelerates The Compounding Potential
- 06/19/2021
|
Clarivate Report Demonstrates that Nations or Institutions with Diverse Research Priorities Respond More Comprehensively to Unprecedented Scientific Challenges
- LONDON, June 16, 2021 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT), a global leader in providing trusted information and insights to accelerate the pace of innovation, today released a new Global Research Report which examines the ability of nations and institutions to respond to unexpected challenges or opportunities in science, medicine, technology and social sciences based on the diversity of their research activities and expertise. With the publication of, " Subject diversity in research portfolios", analysts at the Institute for Scientific Information (ISI)™ at Clarivate consider subject diversity in a research context and show trends in national and institutional research portfolios by examining publications from across the G71 and BRICK2 nations from 1981 – 2018.
- 06/16/2021
|
Clarivate Announces Pricing of Offering of $1.0 Billion Senior Secured Notes and $1.0 Billion Senior Notes
- LONDON, June 10, 2021 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT), a global leader in providing trusted information and insights to accelerate the pace of innovation, announced today the pricing of its previously announced private offering (the "Offering") of $1.0 billion of 3.875% senior secured notes due 2028 (the "Secured Notes") and $1.0 billion of 4.875% senior notes due 2029 (the "Unsecured Notes" and, together with the Secured Notes, the "Notes"). Interest on the Notes will be payable semi-annually on June 30 and December 30 of each year, beginning on December 30, 2021.
- 06/10/2021
|
Clarivate Announces Commencement of Offering of $1.0 Billion Senior Secured Notes and $1.0 Billion Senior Notes
- LONDON, June 10, 2021 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT), a global leader in providing trusted information and insights to accelerate the pace of innovation, announced today the commencement of a private offering (the "Offering") of $1.0 billion of senior secured notes due 2028 (the "Secured Notes") and $1.0 billion of senior notes due 2029 (the "Unsecured Notes" and, together with the Secured Notes, the "Notes"). The Notes are expected to be issued by Clarivate Science Holdings Corporation (the "Issuer"), an indirect wholly-owned subsidiary of Clarivate, subject to market and other conditions.
- 06/10/2021
|
Clarivate Announces Pricing of Offerings of Ordinary Shares and Convertible Preferred Shares
- LONDON, June 10, 2021 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT), a global leader in providing trusted information and insights to accelerate the pace of innovation, announced today the pricing of concurrent offerings of 38,461,538 ordinary shares at a price to the public of $26.00 per share, of which 28,846,154 ordinary shares are being offered by Clarivate and 9,615,384 ordinary shares are being offered by certain existing shareholders (the "Ordinary Share Offering"), and 12,500,000 5.25% Series A Mandatory Convertible preferred shares (the "convertible preferred shares") at a price to the public of $100 per share (the "Convertible Preferred Share Offering," and together with the Ordinary Share Offering, the "Offerings"). Certain existing shareholders have granted the underwriters of the Ordinary Share Offering a 30-day option to purchase up to an additional 5,769,230 ordinary shares.
- 06/10/2021
|
ATOS, NEXT, LEDS, CARV, UNFI, CMTL, DSP, DFH, CLVT, CLOV Stock Prices Fall Intraday
- The stock prices of ATOS, NEXT, LEDS, CARV, UNFI, CMTL, DSP, DFH, CLVT, and CLOV fell during intraday trading. Here is more information about it.
- 06/09/2021
|
Why Clarivate Stock Dropped on Wednesday
- The analytics company announced two concurrent proposed stock offerings.
- 06/09/2021
|
Clarivate Announces Proposed Offerings of Ordinary Shares and Convertible Preferred Shares
- LONDON, June 8, 2021 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT), a global leader in providing trusted information and insights to accelerate the pace of innovation, announced today that it has commenced concurrent proposed offerings of $750 million of ordinary shares, alongside which certain existing shareholders intend to offer $250 million of ordinary shares (the "Ordinary Share Offering"), and $1.25 billion of Series A Mandatory Convertible preferred shares (the "convertible preferred shares") (the "Convertible Preferred Share Offering," and together with the Ordinary Share Offering, the "Offerings"). Neither the completion of the Ordinary Share Offering nor the Convertible Preferred Share Offering is contingent upon completion of the other.
- 06/08/2021
|
Clarivate Forecasts Nearly 70% of North American, European and Asia Pacific Adult Populations Will Be Vaccinated for COVID-19 by September 2021
- New report analyzes how the emergence and increased availability of vaccines will impact the recovery of healthcare markets across the globe LONDON, June 7, 2021 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT), a global leader in providing trusted information and insights to accelerate the pace of innovation, today announced the launch of its COVID-19 Vaccine Availability and Medtech Impact Report which features retrospective, current and predictive analysis to forecast an estimate of the rate at which vaccination will occur in each country in 2021. The report found that, despite continued public health measures in 2021, it is expected that the emergence of multiple vaccines in late 2020 and the rollout of these vaccines globally will determine how healthcare markets recover in 2021 and beyond.
- 06/07/2021
|
Clarivate Partners with Explore IP to Support Canadian Innovation
- Explore IP to integrate Derwent World Patents Index™ global patent data to help organizations increase the marketability of technologies LONDON, June 3, 2021 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT), a global leader in providing trusted information and insights to accelerate the pace of innovation, announced today an exclusive commercial partnership with Explore IP to integrate Derwent™ patent data into its platform. The enhanced Derwent™ patent data will supplement Explore IP's data in an effort to enable businesses, creators, entrepreneurs and innovators discover intellectual property (IP) held by public sector institutions.
- 06/03/2021
|
Clarivate to Present at Upcoming Virtual Investor Conferences in June 2021
- LONDON, May 26, 2021 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT), a global leader in providing trusted information and insights to accelerate the pace of innovation, announced today that Jerre Stead, Executive Chairman and Chief Executive Officer, and Richard Hanks, Chief Financial Officer, will present at the following virtual investor conferences in June 2021. William Blair' s 41st Annual Growth Stock Conference on Wednesday, June 2, 2021 at 10:00 am Central Time.
- 05/26/2021
|
First Ever Clarivate Top 100 Best Protected Global Brands Report Reveals those that Demonstrate Robust Brand Strength and Protection
- Europe leads with almost half of the world's best protected brands; and consumer brands dominate LONDON, May 26, 2021 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT), a global leader in providing trusted information and insights to accelerate the pace of innovation, announced today the first ever listing of Top 100 Best Protected Global Brands. The 2021 report identifies the most impactful and best protected brands in the world, measuring brand strength through the analysis of advanced and unified IP data including trademark information, global case law and digital domain name protection.
- 05/26/2021
|
Why Clarivate Is Buying ProQuest For $5.3 Billion
- Clarivate plc (NYSE: CLVT) announced this week that it is buying ProQuest in a $5.3 billion deal. These are the details.
- 05/18/2021
|
Clarivate to Acquire ProQuest, Creating a Leading Global Provider of Mission Critical Information and Data-Driven Solutions for Science and Research
- LONDON, May 17, 2021 /PRNewswire/ -- Clarivate plc (NYSE: CLVT), a global leader in providing trusted information and insights to accelerate the pace of innovation, today announced a definitive agreement to acquire ProQuest, a leading global software, data and analytics provider to academic, research and national institutions, from Cambridge Information Group, a family-owned investment firm, and other partners including Atairos, for $5.3 billion, including refinancing of ProQuest debt. The consideration for the acquisition is approximately $4.0 billion in cash and $1.3 billion of equity.
- 05/17/2021
|
Clarivate to Present at the Barclays Americas Select Franchise Conference on May 19, 2021
- LONDON, May 13, 2021 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT), a global leader in providing trusted information and insights to accelerate the pace of innovation, announced today that Jerre Stead, Executive Chairman and Chief Executive Officer, and Richard Hanks, Chief Financial Officer, will present at the Barclays Americas Select Franchise Conference on Wednesday, May 19, 2021 at 1:00 PM Eastern Time. A live webcast of the event will be available on the Investor Relations section of the Clarivate website at http://ir.clarivate.com/Event-Calendar.
- 05/13/2021
|
Clarivate PLC (CLVT) Q1 Earnings and Revenues Top Estimates
- Clarivate PLC (CLVT) delivered earnings and revenue surprises of 16.67% and 2.58%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?
- 05/10/2021
|
Clarivate Reaffirms its 2021 Outlook and Provides 2021 Adjusted EPS Outlook
- LONDON, May 10, 2021 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT) (the "Company" or "Clarivate"), a global leader in providing trusted information and insights to accelerate the pace of innovation, today announced that it reaffirmed its 2021 outlook for Adjusted revenues(1), Adjusted EBITDA(1), Adjusted EBITDA margin(1) and Adjusted free cash flow(1) and issued its 2021 Adjusted diluted EPS(1) outlook. Additionally, the Company filed its Form 10-Q for the period ending March 31, 2021 and an amendment to its Annual Report on Form 10-K for the period ending December 31, 2020.
- 05/10/2021
|
Clarivate Announces 2020 Revenue Cycle Awards Recipients
- Winners of the annual award include ThedaCare Regional Medical Center, University of Iowa Hospitals & Clinics and Essentia Health LONDON, May 7, 2021 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT), a global leader in providing trusted information and insights to accelerate the pace of innovation, today announced the 2020 winners of the annual Revenue Cycle Awards, issued by Healthcare Business Insights to US based companies since 2012. The Revenue Cycle Awards recognize healthcare organizations for achieving outstanding performance on revenue cycle KPIs, based on data from their most recent and preceding full fiscal years.
- 05/07/2021
|
Clarivate Reports First Quarter 2021 Results
- LONDON, April 29, 2021 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT) (the "Company" or "Clarivate"), a global leader in providing trusted information and insights to accelerate the pace of innovation, today reported results for the first quarter ended March 31, 2021. First Quarter 2021 Financial Highlights Revenues of $428.4 million and Adjusted Revenues(1) of $431.5 million, both increased 78%.
- 04/29/2021
|
Clarivate Releases Predictive Analytics to Help Fuel Life Sciences Deal Making Landscape
- Cortellis Deals Intelligence features new trends visualizations and predictive analytics supported by artificial intelligence LONDON, April 22, 2021 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT), a global leader in providing trusted information and insights to accelerate the pace of innovation, today announced the enhancement of Cortellis Deals Intelligence, a leading industry source of life science deals information. The new features include deal trend visualizations and predictive analytics, allowing users to confidently track the deal-making landscape and quickly understand the potential value of an asset.
- 04/22/2021
|
Can Churchill Capital Corp. IV Stock Get Back Into Gear?
- The company's car is impressive and so is its factory. But investors still might want to wait awhile before buying CCIV stock.
- 04/16/2021
|
Clarivate Releases Annual Sustainability Report Outlining 2020 Progress and Plans for the Future
- LONDON, April 14, 2021 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT), a global leader in providing trusted information and insights to accelerate the pace of innovation, today published its first ever Annual Sustainability Report. The interactive report outlines the progress Clarivate made in 2020 in the areas of Governance, Environment, Colleagues and Community, and presents plans for 2021 as well as long term goals for the business.
- 04/14/2021
|
Clarivate Appoints Julie Wilson as Chief People Officer and Announces Retirement of Andrea Degutis
- LONDON, April 12, 2021 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT), a global leader in providing trusted information and insights to accelerate the pace of innovation, today announced the appointment of Julie Wilson as Chief People Officer (CPO). She replaces Andrea Degutis who retires after four years at the helm of Clarivate Human Resources.
- 04/12/2021
|
Clarivate Global Research Report Outlines Rising Impact in MENAT Research Due to Strong International Collaboration
- LONDON, April 7, 2021 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT), a global leader in providing trusted information and insights to accelerate the pace of innovation, today released a report which explores the seismic shift of the research landscape in 19 countries across the Middle East, North Africa and Turkey (MENAT) region over recent decades. It presents an international success story, with the region's global share of research output quadrupling from 2% to 8% over the last 40 years, and papers from 22 million individual researchers identified within the region between 2008 and 2017.
- 04/07/2021
|
Churchill Capital IV Stock Price Might Soon Stabilize
- Buy-and-hold investors could consider CCIV stock asa long-term investment around these price levels, and then prepare to be patient. The post Churchill Capital IV Stock Price Might Soon Stabilize appeared first on InvestorPlace.
- 04/02/2021
|
Clarivate to Present at the BofA Securities 2021 Information Services Conference on March 18, 2021
- LONDON, March 12, 2021 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT), a global leader in providing trusted information and insights to accelerate the pace of innovation, announced today that Jerre Stead, Executive Chairman and Chief Executive Officer, and Richard Hanks, Chief Financial Officer, will present at the BofA Securities 2021 Information Services Conference on Thursday, March 18, 2021 at 3:35 PM Eastern Time. A live webcast of the event will be available on the Investor Relations section of the Clarivate website at http://ir.clarivate.com/Event-Calendar.
- 03/12/2021
|
Clarivate Drugs to Watch Report Highlights Four Likely Blockbusters Among Drugs Launching in 2021
- Drug developers advance milestone treatments for chronic and progressive conditions affecting millions of patients worldwide, including Alzheimer's, psoriasis, prostate cancer and congestive heart failure Report also features snapshot of the fast-emerging field of COVID-19 vaccines...
- 03/09/2021
|
Clarivate Releases New Visualization Tool for Multi-Dimensional Individual Researcher Performance
- LONDON, March 1, 2021 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT), a global leader in providing trusted information and insights to accelerate the pace of innovation, today released a new interactive tool that showcases the range of a researcher's publication and citation impact in a...
- 03/01/2021
|
Clarivate Plc (CLVT) CEO Jerre Stead on Q4 2020 Results - Earnings Call Transcript
- Clarivate Plc (CLVT) CEO Jerre Stead on Q4 2020 Results - Earnings Call Transcript
- 02/27/2021
|
Clarivate PLC (CLVT) Tops Q4 Earnings Estimates
- Clarivate PLC (CLVT) delivered earnings and revenue surprises of 29.41% and -3.45%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?
- 02/25/2021
|
10th Edition of Clarivate Top 100 Global Innovators Report Celebrates Innovation Excellence and Quantifies Economic Value of Ideation
- 10-time recipients demonstrated greater market capitalization growth than Dow Jones Industrial Average or S&P 500, according to latest Clarivate Top 100 Global Innovators report LONDON, Feb. 23, 2021 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT), a global leader in providing trusted...
- 02/23/2021
|
Revenue Opportunities Are Missed When The C-suite Doesn't Pay Attention, Says New Clarivate Report
- The proliferation of trademarks and the corresponding increase in infringements present significant challenges and consequences for businesses LONDON, Feb. 18, 2021 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT), a global leader in providing trusted information and insights to accelerate the...
- 02/18/2021
|
